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Abstract 
Current microbial analyses to assess either the commensal microbiota or microorganism 
infection and disease typically require ex vivo techniques that risk contamination and are not 
undertaken in real time. The possibilities for employing imaging techniques in the microbiology 
field is becoming more prominent as studies expand on the use of positron emission tomography, 
ultrasound and numerous microscopy techniques. However, magnetic resonance imaging (MRI), 
a non-invasive in vivo modality that can produce real-time results is falling behind. Here, we 
examined the feasibility of detecting bacteria using clinical field strength MRI. Commensal, 
probiotic and uropathogenic Escherichia coli were scanned by 3 Tesla MRI where signal was 
related to the number of colony-forming units as well as total cellular iron and manganese 
content as determined by mass spectrometry. Various microbes commonly found in the human 
gut and urogenital tract were also assessed by MRI. Lactobacillus spp. displayed significantly 
higher transverse relaxation rates than other species, despite their low iron usage, potentially due 
to high manganese content. High MR relaxivity may enable detection of lactobacilli amidst host 
tissues, therefore, we assessed the potential to distinguish the MR signatures of two distinct cell 
types within mixed samples. With clinical field strength MRI, we were able to detect as few as 
~26 x 106 colony-forming units of Lactobacillus crispatus ATCC33820 per mm3. In the future, 
MRI  may allow for non-invasive evaluation of health or dysbiosis in the human microbiota as 
well as potential applications in tracking the dispersion and persistence of bacteria in broad 
applications from probiotic use, infection to tumour tracking. 
 
Keywords 
Magnetic resonance imaging (MRI), bacterial detection, bacterial tracking, iron homeostasis, 
manganese homeostasis, microbiota, urinary tract infection, E. coli, Lactobacillus crispatus, 
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Summary (lay abstract) 
Background: Bacteria inhabit various niches throughout the human body. These bacteria can 
promote health, but in some cases specific bacteria can overgrow and be harmful to the host. We 
would like to use magnetic resonance imaging (MRI) to visualize and track these bacteria within 
their preferred environments to learn more about human-bacterial and bacterial-bacterial 
interactions in health and disease. 
Hypotheses: Different bacterial types will appear differently on images from MRI. Adding the 
iron uptake gene magA to E. coli will make it easier to detect by MRI. 
Methods: We imaged various bacteria and strains of E. coli found in the human gut and 
urogenital tract using MRI. We then cloned a gene (magA) which incorporates magnetic 
properties into an E. coli strain and then assessed its influence on bacterial MRI detection. We 
measured the concentrations of iron and manganese in all our bacteria since these metals can 
impact MRI. Finally, we imaged dilutions of Lactobacillus crispatus, a bacterium that we found 
to be very visible by MRI and mixed it with human bladder cells to see if we could distinguish 
the two cell types within a mixed sample. 
Results and Significance: Different E. coli strains and bacteria have unique magnetic resonance 
signatures due to differences in metal content. In the future we hope to use MRI to identify and 
track bacteria within the human host.   
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Chapter 1: Introduction 
 
1.1 Bacteriology 
1.1.1 Human microbiota 
Bacterial-host interactions are important, but probably none more so or more complex than the 
human microbiome-human relationship. The microbiome has now been shown to have numerous 
roles, including protecting us from pathogens, producing metabolites for energy and playing a 
major part of our homeostasis, amongst other functions1. Microbiome research has flourished 
over the last decade as researchers uncovered the multitude of roles that gut bacteria play in host 
pathways. Although much has been elucidated, there is still much to learn in terms of bacterial 
dispersion, interactions, and growth in vivo that may contribute to the maintenance of a healthy 
microbiome, and, in some cases, disease. The launch of the Human Microbiome Project led to a 
shift to high-throughput technologies, providing easier and faster identification of microbes and 
the roles they play in the microbiome2, but these samples are still being removed from their niche 
for analysis and these complex microbiome interactions are difficult to replicate outside of the 
host1. Currently, ex vivo analyses are necessary to explore how the microbial imbalances may 
alter host signaling pathways to cause disease or dysbiosis2. Yet, in vivo microbiome analyses 
would be beneficial to complement current ex vivo analyses and to elucidate the factors involved 
in disease manifestation and progression. 
Urinary bacterial communities 
The bladder and urinary tract were previously thought to be sterile in healthy individuals, but we 
now know that is untrue3. In healthy individuals, the lower urinary system is dominated by 
species of lactobacilli and most frequently, members of the Lactobacillus crispatus species. 
While the microbiota of the urinary system is more complex than the absence or presence of 
these commensal microbes in health or disease, it represents a much simpler microbiota to 
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commence studies with than that of other sites in the body, with lower microbial diversity and 
reasonable densities, enabling more rapid human studies in this area. Our study will focus mainly 
on the urinary microbiota as this niche will be an ideal starting point for in vivo bacterial 
detection by MRI. Not only will the low microbial diversity allow for more simple analysis of 
future in vivo microbial samples, but the lack of gas pockets and motion compared to other 
microenvironments (like the human gut) will be helpful for minimizing imaging artifacts. 
Bacterial-host interactions, function, and the dispersion of microbes in vivo are not well-studied 
in disease, especially not in those where our model organism (Escherichia coli) is typically 
prevalent, such as urinary tract infection (UTI) or in the microbiome where it has a sustained 
presence. There is still much to learn in microbiome research, and complementing ex vivo 
analyses with in vivo imaging may be beneficial for observing the true nature of bacterial growth, 
dispersion, and behaviour. 
1.1.2 Urinary tract infection 
Studies show that a significant portion of patients in hospitals require urinary catheters and over 
half of these patients will experience UTI4, especially in cases of long-term catheterization5. UTI 
recurrence is common and usually becomes chronic since biofilm formation allows the bacteria 
to become more resistant to antibiotics, host defenses and shearing forces, which in turn allow 
them to survive and re-colonize the urinary tract5. Differences in attachment between bacterial 
species and strains are prompted by catheter composition. Although many catheters are currently 
made of silicone, other materials and coatings are being studied to prevent bacterial attachment5. 
Other research has explored if there is an ideal antibiotic to delay biofilm formation on catheters 
and potential for flushing catheters with this antibiotic before insertion may minimize UTIs6.  
Although E. coli are commonly found in the human gut as commensal microbiota, they are the 
most common culprits of urinary infection due to their tendency to form biofilms. When 
transitioning from a planktonic form to a biofilm-forming bacteria, the cells must change their 
gene expression, especially of their virulence factors4 to promote adherence7. It is important to 
study E. coli behaviours and dispersion during planktonic growth as well as during and following 
biofilm production to elucidate new pathways that can be targeted by molecular imaging. These 
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changes in growth form may lead to differences in contrast by molecular imaging or help explain 
any unexpected results. Due to the interest in E. coli’s biofilm structure, researchers have 
undertaken various ex vivo studies using imaging techniques, including matrix-assisted laser 
desorption ionization-time of flight imaging mass spectrometry (MALDI-TOF IMS)7 and 
magnetic resonance imaging (MRI)8.  
In UTI, type I pili are important for adherence, but not necessary for biofilm formation, especially 
under anaerobic conditions, indicative that this virulence factor is temporally regulated during 
biofilm formation7. Hadjifrangiskou et al. (2012) reiterate the importance of type I pili, as well as 
flagella and curli (a bacterial protein that acts as an extracellular matrix) which are necessary but 
not sufficient for biofilm formation4, indicative that further examination of biofilm-associated 
genes is warranted. Some work has been done using nuclear magnetic resonance (NMR) to study 
biofilms in situ, particularly to observe metabolism in intact, live biofilms9. Another study of 
interest looked at substrate transport into biofilms through diffusion using NMR. Here they found 
that relaxation rates were reduced within the biofilm due to the relative immobility of fluids 
especially around the boundary of the biofilm8. The researchers were able to use these magnetic 
resonance (MR) measures to map the location of the biofilm’s boundary, the biofilm thickness and 
area, as well as the diameter of the catheter’s lumen where liquid is still able to flow and shearing 
stress by flow is active8. Overall, these methods may be useful for complementing the analysis of 
biofilm structure and composition by molecular imaging. 
1.1.3 Bacterial metal homeostasis 
Iron 
Iron uptake and storage is tightly regulated in E. coli; however, these regulatory mechanisms 
may be impacted by biofilm formation, bacteria-bacteria interactions, or bacteria-host 
interactions. Escherichia coli require approximately 10-5 – 10-7 M iron to grow optimally, this 
works out to anywhere from 105 – 106 iron atoms per bacterial cell10. Like all prokaryotes, E. coli 
use ferritin proteins to store intracellular iron in a readily available form for use in metabolism 
while preventing the iron from interacting with reactive oxygen species and causing cell damage 
and toxicity11. These bacteria also produce bacterioferritins which act similarly to ferritins and 
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are commonly co-expressed11. Iron uptake in E. coli is tightly regulated through ferric uptake 
regulator (Fur): when Fur binds free iron, it responds by repressing the transcription of iron 
uptake genes11, 12. A previous study using Mossbauer microscopy found that intracellular iron in 
E. coli is stored in aggregates of ferritin, and soluble iron accounts for less than 1% of the total 
cellular iron13. The iron uptake and storage of these bacteria are important to keep in mind as we 
consider the possibility of labelling them for molecular imaging. 
Though all E. coli are rod shaped, there is some strain to strain size variation14 and even 
intrastrain size variation15. Differences in iron acquisition genes and metabolic needs of strains 
may explain variability in cellular iron content since, as discussed above, iron acquisition genes 
are virulence factors contributing to bacterial pathogenesis. For example, certain UPEC encode 
siderophores such as salmochelin and aerobactin on their pathogenicity islands to improve 
survival in low iron environments16. Although these high affinity, low molecular weight ferric 
chelators are more plentiful in pathogenic bacteria, many bacteria encode genes involved with 
active iron uptake to enable their survival in low iron environments. Gram negative bacteria use 
outer membrane receptors paired with periplasmic shuttling proteins and ATP-binding cassette 
(ABC) transporters in their inner membrane to facilitate the uptake of siderophore-acquired 
iron10. Gram positive bacteria use a similar ABC transporter tethered to their membrane via a 
lipoprotein17.  
Manganese 
Iron and manganese uptake are linked in UPEC expressing the sitABCD operon within their 
pathogenicity island(s)18. The genes in this operon include those encoding iron and manganese 
uptake proteins that are regulated by transcription factors involved in the Fur system as well as 
the MntR manganese regulator19. The combined regulation of iron and manganese uptake and 
enormous genetic intrastrain variability supports the similarity in trends between iron and 
manganese content in UPEC strains, but not necessarily in the lab or commensal E. coli strains. 
Although manganese is not as crucial a cofactor for many bacteria, it can act as a substrate for 
some metalloproteins in iron deplete conditions20. However, manganese is unable to activate 
many metalloproteins, rendering them useless20. Manganese uptake is mediated by MntH, so to 
limit manganese import in high Mn conditions, manganese-bound MntR represses the 
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transcription of this importer20. Many bacteria also produce manganese efflux pumps, like MntP 
found in E. coli. MntS expression is also repressed by manganese-bound MntR and it has been 
suggested that when expressed, MntS may inhibit MntP, thereby decreasing Mn efflux and 
effectively increasing intracellular manganese content20. 
While iron is critical in most bacteria, manganese is critical for the growth and survival of 
lactobacilli21. Manganese is an important cofactor for many enzymes in lactobacilli, including 
lactate dehydrogenase, RNA polymerase and xylose isomerase22. 
Both the iron and manganese handling capabilities of different bacteria are important to consider 
when exploring the possible applications of imaging bacteria by MRI. 
 
1.2 Imaging applications in bacteriology 
The use of molecular imaging techniques has vastly expanded over the last decade, with an 
emphasis on greater interdisciplinary use, extending into cancer research, cell biology and 
microbiology. Here, we highlight the various imaging applications in microbiology to date and 
how we can apply imaging more effectively in the future. 
1.2.1 Advanced microscopy techniques in microbiome research 
Microscopy is one of the most broadly used techniques, however there are many different 
subtypes that can be used to visualize minute subcellular structures, through fluorescence 
microscopy and confocal microscopy. A recent study using fluorescence in situ hybridization 
(FISH)23 to explore bacterial dispersion in the gut microbiome within gnotobiotic mice found 
that bacteria within the microbiota are very dynamic, with rapid turnover and cellular shedding 
preventing aggregations and homogeneous bacterial dispersion23. Earle et al. (2015) also used 
FISH to explore the factors that influence bacterial dispersion in the gut microbiome in vivo. 
Though their imaging was done after sacrificing their mice, their study was still important in 
defining the relationship between luminal mucus thickness and proximity of bacteria to the 
epithelium24. In their gnotobiotic mice, the group also found that presence of Helicobacter pylori 
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within the microbiota was correlated to increased mitotic figures and more proliferative, and 
potentially cancerous, gastric cells were commonly found around H. pylori. Finally, they were 
able to visualize a near homogeneous mixture of bacteria after allowing the community to 
stabilize, with few large bacterial clumps, but most clumping caused by Bacteroides24, 
commonly the most abundant genus within the human gut. These FISH studies are great tools for 
exploring bacterial dispersion and interactions combining both highly specific fluorescence 
imaging techniques with high resolution confocal technology. Current FISH studies are 
conducted post-mortem, but perhaps future technological advancements will enable live non-
invasive imaging. 
1.2.2 Bioluminescence and bacteria 
Bioluminescence imaging (BLI) studies are informative but applications are limited since 
infections are caused by non-bioluminescent bacteria25, 26 and poor spatial resolution caused by 
light scattering. Nonetheless, imaging luciferase reporter genes is commonly used in small 
animals, including mouse studies tracking bacteria over the course of infection27. Rodea et al. 
(2017) used BLI to learn about enterotoxigenic E. coli pathogenicity and colonization. By 
constitutively expressing the luciferase operon in these pathogens, the group was able to 
visualize bacterial adherence and persistence in the murine colon over time though they 
expressed troubles with the poor penetration depth27. Merrit et al. (2016) did not encounter such 
issues as they used BLI to visualize the oral microbiota and biofilm formation, where penetration 
depth is negligible. Here they expressed luciferase genes in several common oral Streptococcus 
spp., quantifying as anywhere from 102 - 104 CFUs28, demonstrating the great sensitivity of this 
technique. 
1.2.3 Bacterial tracking via ultrasound 
Few studies are exploring the applications for US in bacteriology. Shapiro et al.(2014) examined 
the potential for gas vesicles to provide photoacoustic contrast using purified gas vesicles from 
two distinct bacterial sources. They found a 3.7 - 4.5-fold increase in US contrast in comparison 
to a linear scattering reference material29. This was followed up by Bourdeau et. al. (2018) 
genetically engineered E. coli to express acoustic reporter genes in the form gas vesicle genes 
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from Bacillus megaterium. Once expressing these genes, the E. coli were injected into the lumen 
of a murine colon, followed by photoacoustic (US) imaging and BLI to track the bacteria in 
vivo.30 As few as 5 × 107 cells/mL could be detected, which they calculated to approximately 100 
bacterial cells per voxel. Finally, they assessed their acoustic reporter genes in Salmonella 
typhimurium for future tumour tracking applications and were able to track the bacterial cells by 
US, but not BLI30, suggesting US may be superior to BLI for some applications.  
US has also been applied to biofilm studies, with researchers causing gas bubble build up on 
biofilm surfaces to improve their detection31. Gas vesicles bound to TRITC-labelled streptavidin 
bound to biofilm surfaces proportionally to the size of the biofilm. They suggest that their 
technology could be used to detect both early- and late-stage biofilm formation in vivo31. These 
findings would be interesting to apply to urological studies where many UTIs and catheter or 
stent fouling is caused by biofilm formation. 
1.2.4 Positron emission tomography applications in microbiology 
Positron emission tomography is a highly specific method that uses radionuclides to detect 
tissues or molecules of interest, generally through receptor mediated interactions. Recently, this 
modality has been the most widely explored for interdisciplinary bacteriology applications. The 
most common clinically relevant PET tracer is [18F]fluoro-deoxyglucose ([18F]-FDG), a glucose 
analog that enters cells, becomes phosphorylated and trapped, leading to 18F accumulation within 
the cell, which can then be measured. More metabolically active cells – including cancer cells or 
proliferating immune cells – take up more of the tracer than background tissues, leading to a 
higher standardized uptake value (SUV). PET is becoming increasingly useful in microbiological 
studies to detect sites of inflammation or infection, to follow bacterial localization in vivo, and 
more recently to explore the gut microbiota. For example, Garrido et al. (2014) used [18F]-FDG 
to monitor infection and treatment of Staphylococcus aureus biofilms in vivo in catheters 
implanted subcutaneously in mice26. Here, they detected an increase in tracer uptake (or SUV) 
following infection and decreased SUV following treatment with rifampin, but they found that 
they were unable to distinguish the signal from bacteria compared to inflammatory cells26. This 
brings to question whether [18F]-FDG is the proper probe for detecting bacteria. In 2017, Heuker 
et al. also evaluated the potential to use [18F]-FDG to detect live bacterial infections32. This in 
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vitro study used a variety of Gram-positive and Gram-negative bacterial isolates incubated with 
the radiotracer and assessed uptake with microPET and by using a gamma-counter. They found 
differences in uptake between bacterial species as well as differences in rates of uptake, where 
Streptococcus pyogenes displayed the highest tracer uptake. They also determined that viable 
bacteria were able to take up more tracer than heat-killed bacteria32, but they did not take into 
account the inflammatory cells that would be present in vivo and that other groups already 
showed contribute significantly to [18F]-FDG uptake. Since [18F]-FDG is not bacteria-specific, 
Mills et al. (2015) used a phosphorylated form, [18F]-fluorodeoxyglucose-6-phosphate ([18F]-
FDG-6-P) that was shown to enter Gram-positive and Gram-negative bacteria through universal 
hexose phosphate transporters (UHPTs) that are not present in mammalian cells33. This 
radiotracer results in more specific uptake at sites of infection over sites of inflammation alone 
(hereby referred to as sterile inflammation). The authors used S. aureus UHPT-deficient mutants 
to confirm the necessity of UHPT for tracer uptake as well as to confirm that various mammalian 
cells were unable to transport the probe across their lipid bilayer. They found less [18F]-FDG-6-P 
uptake in mammalian cells compared to [18F]-FDG, producing a lower background signal with 
this new probe and higher SUV ratio in infected vs. uninfected mouse flanks33. This study also 
used a bioluminescent S. aureus strain for their mouse studies to verify their PET data33. 
Although [18F]-FDG-6-P was not taken up by any of the cancer cell lines they evaluated, there is 
a possibility for tracer uptake by mammalian cells33, thereby limiting the probe’s utility for 
bacterial-specific uptake and due to its potential homing to sites of sterile inflammation.  
Earlier studies aiming to image infection mostly targeted immune cells rather than the microbes 
themselves. In 1990, Fischmann et al. prepared pentetic acid (DTPA) bound chemotactic peptide 
analogs radiolabeled with 111I 34. These probes were able to bind chemokine receptors on human 
innate immune cells and reveal localization at the site of infection as immune cells migrated 
toward their target34. The main issue with these probes, as discussed earlier, is their inability to 
distinguish infection from inflammation alone, leading to a push for microbe-specific probe 
generation. Early bacteria-targeting studies evaluated probes such as 1-(2'-deoxy-2'-fluoro-β-D-
arabinofuranosyl)-5-[125I] iodouracil ([125I]FIAU)35 and [18F]-2'-Fluoro-2'-deoxy1h-D-
arabionofuranosyl-5-ethyl-uracil ([18F]FEAU)36. In 2005, Bettegowda et al. assessed the single-
photon emission computed tomography (SPECT) probe [125I]FIAU in murine E. coli infections 
and found that it could be used to detect both Gram-positive and Gram-negative bacterial 
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species. They also used Clostridium novyi-NT intravenous infusion in mice along with the 
radiotracer to visualize tumours by SPECT35. A more recent study using [125I]FIAU to look at 
lung infections found that although the tracer uptake was specific to infection over sterile 
inflammation, the sensitivity was quite low37. Pullambhatla et al (2012) could only visualize 
bacterial burdens above 109 CFUs/mL37, 1000 – 10,000-fold higher than the threshold for 
bacterial infection. Brader et al. (2008) compared [18F]FEAU to both [18F]-FDG and [125I]FIAU 
to image E. coli Nissle 1917 localization to tumour sites36. They found a linear correlation 
between [18F]FEAU accumulation and the number of viable bacteria, however [18F]-FDG 
showed more accumulation at the tumour site (where E. coli were present). Although the 
background signal for both [18F]FEAU and [125I]FIAU were better than for [18F]-FDG36, there 
are currently much better options as new radiotracers are being produced. 
In the search for a better bacterial-specific PET tracer, Ning et al. (2014) produced a new probe, 
18F labelled maltohexaose (MH18F), that targets the maltodextrin transporter present on all 
bacteria38. This new probe was able to detect as few as 105 CFUs of E. coli, resulting in a more 
sensitive method of imaging bacteria in vivo for detecting earlier stages of infection. In general, 
105 – 106 CFUs/mL of bacteria are considered the threshold for infection. Researchers showed 
that MH18F produced a 30-fold increase in SUV in infected tissues compared to uninfected 
tissues, whereas [18F]-FDG only produced a 1.5-fold difference38, demonstrating the added utility 
of a bacteria-specific probe for microbial imaging. There was also a significantly decreased SUV 
in sodium azide-treated (non-metabolically active) bacteria compared to healthy bacteria38. 
Gowrishankar et al. (2014) used a similar novel PET tracer, 6-[18F]-fluoromaltose, that was also 
able to enter bacteria through the maltodextrin transporter39. This study also found that the 
maltodextrin-based probes are specific to bacteria, both Gram-negative and Gram-positive, but 
unable to be taken up by tumour cell lines. They also found that macrophage-internalized 
Listeria monocytogenes was unable to take up the tracer until it became extracellular again. SUV 
was increased significantly in vivo in a mouse E. coli induced myositis model compared to 
uninfected controls, and SUV was only increased in live bacteria, not in the heat-killed 
controls39. No changes were seen in sterile inflammation compared to uninfected mice as well as 
little gut accumulation, providing lower background signal. The 6-[18F]-fluoromaltose probe was 
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deemed sensitive to 106 CFUs39, meaning it is slightly less sensitive than the MH18F probe, but 
still able to detect the clinical threshold for most infections.  
More recently, Neumann et al. (2017) evaluated different PET probes that take advantage of the 
amino acids specific to bacterial peptidoglycan synthesis. They found that [14C] D-Met was the 
best candidate for bacterial targeting since both Gram-positive and Gram-negative bacteria 
incorporate it selectively over the L-Met enantiomer40. The transpeptidases that use D-Met as a 
substrate for peptidoglycan synthesis are promiscuous and allow radionuclides to be incorporated 
without slowing down cell wall synthesis. Neumann et al. found that [14C] D-Met was not taken 
up by heat-killed bacteria or in a model of sterile inflammation, but SUV was much higher in E. 
coli or S. aureus murine myositis models40. High background in the respiratory and 
gastrointestinal tracts limits the utility for monitoring infections in these areas40, however it may 
be useful to image the microbiota in those areas to learn more about those bacterial interactions 
and activities. 
1.2.5 Bacteriology and magnetic resonance imaging 
In a bacterial MRI study, the researchers were able to define the boundaries of biofilms using 
T2-weighted MR images8. Hill et al. (2011) also used MRI to explore iron loading in planktonic 
E. coli Nissle through overexpression of iron storage proteins including ferritin and 
bacterioferritin. Here they found both in vitro and in vivo that increased iron storage leads to 
higher iron uptake – possibly by siderophores – and increased R2 relaxivity41. One weakness of 
the study was use of a 7T MRI system which is not currently approved for clinical use. We 
propose that further advances can be exploited by using MRI at 3T to obtain more clinically 
relevant data and provide ease in translation from the lab to the clinic. 
Hoerr et al. (2013) wanted to label S. aureus cells with iron oxide nanoparticles to monitor 
infection. They started by labelling E. coli where the negatively charged lipopolysaccharide on 
the bacterial outer membrane enabled easy labelling with the positively charged nanoparticle42. 
In vitro MRI at 9.4T was performed at various time points post-labelling to assess dilution of the 
label. This label dilution was important for tracking infection over time in their in vivo mouse 
model. For labelled S. aureus, a blooming artifact was evident in T2*-weighted images42 due to 
11 
 
local field inhomogeneities. Overall in this study they were able to reliably detect 105 CFUs42, 
right at clinically relevant bacterial levels. 
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Table 1. Potential for imaging modalities in bacteriology  
Modality Resolution Potential 
applications 
Benefits Limitations References 
MRI 1 mm • Tracking iron-
labelled 
bacteria, or 
those with 
high MR 
relaxivity 
• Multimodality 
imaging 
• Non-invasive 
• High 
sensitivity 
• Potential for 
imaging 
bacteria 
without 
labelling 
• Low 
specificity 
• Expensive 
• Can be time 
consuming 
8, 41, 42 
PET 3 – 5 mm • Detection of 
specific 
bacterial 
species 
• Multimodality 
imaging 
• Non-invasive 
• High 
specificity 
and 
sensitivity 
• Require 
radioisotopes 
• Must label 
target 
• Expensive 
26, 32, 33, 35-
37, 39, 40 
US 0.1 mm • Deep tissue 
bacterial 
tracking 
• Non-invasive 
• Deep 
penetration 
depth 
• High spatial 
resolution 
• Accessible 
• Low 
specificity 
• Requires 
bacterial 
labelling for 
good 
resolution 
29-31 
FISH < 1 mm • Exploring 
bacterial 
interactions 
and dispersion 
• High 
specificity 
and 
sensitivity 
• Ex vivo 
• Low 
penetration 
depth 
• Require 
fluorescence 
labelling 
23, 24 
BLI >  5 mm • Multimodality 
imaging 
• Superficial 
bacterial 
detection and 
tracking in 
vivo 
• High 
specificity 
• Target must 
express 
bioluminesce
nce genes 
• Superficial 
imaging only 
27, 28 
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1.3 Magnetic resonance imaging 
MRI uses magnetic fields and radiofrequency (RF) radiation to detect the magnetic moment of 
protons, a magnetic property that can be measured. Each proton has a magnetic moment. In the 
absence of a magnetic field, the direction of these magnetic moments are randomly distributed so 
there is no net magnetization produced43. An MRI scanner incorporates a large magnet that 
produces a magnetic field referred to as B0. This B0 field is often aligned with the Z-direction of a 
coordinate system that is used to describe the process of image formation, where the XY-plane is 
perpendicular to the direction of the magnet bore. When placed in a magnetic field, the magnetic 
moment associated with the protons in tissues precesses around B0, with the Z-component of the 
magnetic moment aligned either parallel or antiparallel to B0. The parallel condition is slightly 
favoured leading to an overall net magnetization in the direction of B0 
43.  To produce an image 
this net magnetization is manipulated by a series of RF fields and magnetic field gradients.  The 
RF fields rotate the net magnetization away from the Z-axis so that a component of the net 
magnetization lies in the XY plane. Linear magnetic field gradients can then be used to encode the 
position of protons within the sample to create an image43.  After the application of the RF fields 
to perturb the magnetization, the proton magnetic moments take some time to return to their 
original distribution and alignment in the Z direction and for the coherence of the magnetization 
to decay within the XY-plane (Figure 1). The rate of realignment can vary depending on the 
environment of the proton. Examples of different proton environments would be water trapped in 
a cell and water in extracellular fluid.  
The time for the net magnetization vector to return to its equilibrium state aligned with B0 is 
characterized by a time constant T1 that is called the longitudinal relaxation time constant. This 
time constant is affected by the energy exchange between protons with the surrounding magnetic 
and thermal environment. The loss of phase coherence of the transverse (XY) component of the 
magentization is characterized by the transverse relaxation time constant, which represents the 
time to decay to 1/e of its initial value43. There are three different types of transverse relaxation, 
known as T2*, T2 and T2', that will be discussed in this thesis. It is often convenient to refer to the 
associated relaxation rates (R2 = 1/T2, R2* = 1/T2*, R2' = 1/T2'. R2* is the total transverse 
relaxation rate, and is equal to the sum of the other two rates (R2* = R2 + R2'.)  R2 is often called 
the irreversible transverse relaxation rate because that part of the decay can not be reversed with 
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RF refocusing pulses (see spin-echo sequence below), whereas R2' is reversible. Transverse 
relaxation is especially impacted by magnetic field inhomogeneities from iron44. Clustering of 
magnetic nanoparticles causes a decrease in both R2 ad R2' relaxation as the magnetic particles 
generate local magnetic fields that cause the surrounding protons to dephase45. This means that the 
net magnetization in the XY-plane disappears faster than it would in the absence of iron. These 
measurements affected by iron labelling can be exploited for imaging bacteria in vivo, These 
relaxation rates, or relaxivity, increase with increased levels of iron. 
Magnetic resonance imaging (MRI) is a non-invasive in vivo molecular imaging technique with 
high spatial resolution and depth of penetration, but it has poor specificity46. However, it is still 
one of the most frequently employed clinical imaging modalities since it does not require the use 
of radioisotopes46. The greater the magnetic field strength, the greater the resultant net 
magnetization vector within the sample because the number of protons with magnetic moments 
that align along B0 increases proportional to B0.  
15 
 
Figure 1. Effect of MRI on magnetization. Protons within a sample each have their own 
magnetic moment with no net magnetization vector. In the presence of the main magnetic field 
(B0) from an MRI most protons align parallel or antiparallel to the magnetic field, leading to a 
net magnetization vector in the direction of B0. An RF pulse (B1) is applied perpendicular to B0 
to tip the net magnetization vector into the XY plane and R1 and R2 decays are obtained as the 
magnetization in the Z-plane regrows (Mz) and the XY component (Mxy) decreases respectively.   
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1.3.1 Sequences  
Spin-echo sequence 
Spin echo (SE) sequences use a 90˚ RF pulse to tip the net magnetization from its alignment 
along the Z axis (parallel to the main magnetic field, B0) into the XY plane. Next, a 180˚ pulse is 
applied at a time TE/2 after the 90˚ RF pulse, where TE is the echo time. This 180˚ RF pulse 
rephases the spins that were aligned in different directions in the XY plane, due to magnetic field 
inhomogeneities. The signal acquisition occurs at a time TE/2 after the 180˚ RF pulse, i.e., at a 
time TE after the 90˚ RF pulse. As TE increases the signal intensity decreases due to T2 
relaxation, i.e., this is the irreversible decay. The pairs of 90˚ and 180˚ RF pulses are repeated 
while varying magnetic field gradients in a prescribed method to acquire a full image. The 
repetition time (TR) is the time between these 90˚ excitation RF pulses. As signal intensity is 
measured at varying TE, all signal intensities decrease as TE increases, but the rate of this signal 
decay varies, measured as R2. In SE images, the signal intensity is low in tissues with a short T2 
and is comparably higher in tissues with a long T2. Fluids, which have long T2 (i.e., low R2), 
appear bright, whereas tissues, which are packed with cells, have high R2 and appear gray.  
Gradient echo sequence 
Gradient echo (GRE) sequences use a single 90º excitation RF pulse in combination with 
magnetic field gradients to produce an echo.  No refocusing pulses (i.e., no 180˚ pulse) are 
utilized. For the gradient echo, TE is the time from the RF pulse to the centre of the gradient 
echo. As with SE imaging, signal intensity decreases with longer TE, but the rate of signal decay 
varies. Signal decay as a function of TE is due to R2* relaxation which includes both R2 
relaxation and static dephasing associated with magnetic field inhomogeneities. Unlike R2, R2* 
is not an intrinsic property of the tissue since any imperfections in the tissue composition, 
including the presence of  nearby air spaces and metal ions can alter the rate of signal dephasing 
due to the generation of localized magnetic field gradients. 
Inversion-recovery sequence 
Inversion recovery (IR) sequences can be used to obtain longitudinal relaxation rate 
measurements through the acquisition of T1-weighted images. In this sequence, a 180° RF pulse, 
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or an inversion pulse, inverts the longitudinal magnetization before applying the 90° excitation 
pulse. The inversion time (TI) refers to the time between these two pulses. The sequence is 
repeated with varying TI; there is little time for T1 signal recovery during short TI so the signal 
acquired is negative, whereas longer TI allow for T1 recovery and positive signal acquisition. 
These positive and negative echoes are plotted as IR curves to obtain R1 measurements. The 
proton density (or water content) of an imaged tissue impacts R1. 
1.3.2 Effect of metals and contrast enhancement on MRI 
Magnetic metals, including ferro-, para- and diamagnetic ions cause local field inhomogeneities 
and enhance transverse relaxivity within a sample. Though many metals impact MRI, the effects 
of paramagnetic particles like manganese on MRI are orders of magnitude weaker than those of 
ferromagnetic (iron) particles47.  
Magnetic resonance signals can be manipulated by using contrast agents, both exogenous or 
endogenous, to improve target specificity46. Exogenous contrast agents, such as 
superparamagnetic oxide nanoparticles (SPIO), are injected into the patient and shorten the rate of 
transverse relaxation. Endogenous agents are produced and expressed by the patient’s cells and act 
similarly to exogenous agents, however, there are a few key advantages of endogenous contrast 
agents. Exogenous contrast agents dilute with cell division, are injected once and then degrade and 
dissipate from the target site. This causes decreased MR signal over time48 and requires injections 
each time patients are scanned. Endogenous agents are replicated in each cell, passing the 
contrasting material onto daughter cells during mitosis. therefore the signal remains 
longitudinally46 for long-term cell labelling. It is also possible to explore cellular activities when 
using endogenous agents since the cell must be alive to produce the contrast49. In addition, there 
is the potential for reporter-gene based expression, where contrast is measured when a specific cell 
signalling pathway becomes activated or when specific ligands are present. Overall, development 
of endogenous contrast agents is necessary for earlier detection and intervention in disease, 
especially in patients requiring repeat MRI sessions.  
Iron-related contrast agents are popular for MRI as they affect transverse relaxation rates, 
including R2, R2*, and R2' 50. These MR measurements are impacted by magnetic field 
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inhomogeneities from iron44. Zhou et al. (2017) found that clustering of magnetic nanoparticles 
causes a decrease in T2 relaxation45. Since T2 is inversely proportional to R2, we see an increase 
in R2 measurements. These magnetic nanoparticles lead to generation of a local magnetic field 
which causes the surrounding protons to dephase45. These key measurements are affected by iron 
labelling, can be exploited for imaging bacteria in vivo, and are used in our study to quantitatively 
measure the effect of iron in bacteria.  
Endogenous, gene-based agents for long-term contrast and the monitoring of cellular activities49 
has been previously demonstrated in mammalian cells by expressing single genes50, and in non-
magnetic bacteria with full operons from magnetotactic bacteria (MTB)51 to improve iron uptake 
and retention, thereby imparting MR contrast enhancement. 
1.3.3 Magnetosomes, MagA and their applications in molecular 
imaging 
Magnetotactic bacteria are gram negative anaerobes that produce iron biomineral compartments, 
or magnetosomes, to impart magnetic properties and align along magnetic fields. These 
magnetosomes are produced in a protein-mediated stepwise manner starting with membrane 
invagination to form intracellular vesicles51. These magnetosome vesicles take up iron and 
biomineralize complex iron particles that vary based on the species of MTB. For example, 
Magnetospirillum magneticum sp. AMB-1 produce magnetite which is stored in magnetosome 
vesicles that assemble into chains along the cytoskeleton51. The proteins that permit this process 
to take place are well conserved between MTB species, and many are encoded on a distinct region 
of the genome termed the magnetosome genomic island (MAI). To determine which genes may 
be essential for magnetosome production, Kolinko et al. (2014) cloned full operons of the genes 
in non-magnetic bacteria. They speculated that only a subset of the MAI genes are required for 
magnetosome formation and that systematic analysis of each gene will help to uncover those that 
are necessary51. One of these potentially important magnetosome genes, mamK, has been cloned 
into E. coli and shown to play a role in positioning the magnetosomes along the cytoskeleton52. 
The idea of magnetosome gene regulation by induction may be useful in future studies to restrict 
any toxic effects that accompany iron retention. For example, Pradel et al. (2006) regulated mamK 
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gene expression using arabinose-mediated induction. A similar study cloning mamK into E. coli 
used isopropyl-β-D-thiogalactopyranoside (IPTG) to induce the gene expression 53. 
 A gene from AMB-1, magA, was previously characterized to encode a non-selective iron uptake 
protein54. This characterization involved cloning a strain of E. coli to express the gene in a bacterial 
expression plasmid. They found that MagA shared homology with KefC, a K+ efflux pump in E. 
coli, however this homology did not reflect function. Instead, they found that MagA functioned as 
a membrane-bound ATP-dependent iron transporter. They further suggested that magA expression 
is regulated similarly to the Fur system in E. coli54 since the sequence of Fur within 
Magnetospirillum MTB is well conserved and these sequences are quite similar in M. magneticum 
and M. magnetotacticum12. At the very least, Fur seems to be involved in iron homeostasis and the 
regulation of MTB biomineralization12. Another study found that magA expression was increased 
in iron deficient conditions but partially repressed in iron replete conditions55, suggesting the 
possibility for Fur-mediated regulation. These researchers also found through electron microscopy 
that MagA may interact with the magnetosome membrane55. A more recent study of magA found 
that the gene was not conserved in all MTB and was not located on the MAI56. These findings 
suggest that magA may not be important for magnetotaxis since magA deletion mutants showed 
no phenotypic effects and still produced magnetosomes, indicating that MagA is either not 
essential or not involved in magnetosome formation56.  
Using magnetosomes for MR contrast enhancement may be advantageous over SPIO since they 
share similarities, including size, composition, and response to magnetic fields49. Biological 
magnetosomes tend to have more uniform crystal size as well as more even dispersion than their 
synthetic counterparts57. These differences may be attributed to the natural lipid bilayer that 
surrounds the magnetosomes. That lipid bilayer allows for a larger crystal to form, which 
seemingly provides better magnetic properties. To explore this further Hu et al. (2010) compared 
synthetic nanoparticles and biological magnetosomes in varying concentrations by proton NMR 
and analyzed the T1 and T2 effects. They saw increasing signal attenuation in both T1 and T2 
weighted images with increasing magnetosome concentration, as expected. The signal decayed 
faster in samples of bacterial magnetosomes, which was attributed to increased inhomogeneities 
within the magnetic field57 due to the presence of concentrated magnetite iron particles. The main 
shortcoming in this study was the lack of phantom for air exclusion to minimize artifacts. Also, 
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the FLAIR and fast SE sequences they used to acquire their MR data are very different from our 
own. That combined with the minimal quantitative data (mostly displayed as T1/T2 ratios) provide 
a barrier for direct comparison MR relaxivity of purified magnetosomes to that of the wildtype 
bacteria within our study. Other groups have found that increasing concentrations of 
magnetosomes lead to lower T2 in vivo, enabling labelling for up to 28 days46. This longitudinal 
labelling may aid in early diagnosis of disease as well as monitoring, or even theranostics46. 
Single MTB genes like magA49, 58 or mms659 have been employed to improve iron uptake/retention 
and impart magnetic properties and improve MR contrast. Full operons of MTB magnetosome 
genes have been cloned into a non-magnetic bacterium, Rhodospirillum rubrum, to elucidate their 
functions51. MagA expression in mammalian cells increases cellular iron and transverse (R2, R2*) 
relaxivity48, 49. Though iron loading can be detrimental to cells, and toxicity has been noted 
following high levels of MagA induction in some mammalian cells48 but not others49, 50, MagA-
mediated toxicity in bacterial cells has yet to be reported and previous E. coli studies found no 
toxic effects54. A recent study used a lentivirus to provide inducible MR contrast by MagA for 
monitoring stem cell grafts longitudinally48. They observed cytotoxicity and reduced proliferation 
rates upon induction of MagA expression. Nonetheless, increases in cellular iron were measured 
following MagA expression which correlated to increased R2 in vivo48. The technique to induce 
MagA expression used by Cho et al. (2014) may be beneficial in pursuing MagA as an MRI 
reporter gene to minimize detrimental iron accumulation and control cytotoxicity, although this 
toxicity was not seen in other mammalian cell lines such as N2A49, or MDA-MB-43550. A study 
where adult stem cells were labelled with MagA found MagA-associated cytotoxicity in both 
mouse kidney stem/progenitor cells and mouse mesenchymal/stromal cells60. However, they did 
find that human embryonic kidney cells transduced with magA were viable, and as previously 
reported, showed MR relaxation rates correlated with iron content. They suggest that MagA as a 
reporter gene system may not be feasible for all cell types. Pereira et al. (2016) also proposed that 
magnetosome-like particles previously observed may simply be ferritin clusters which also have 
applications in MR contrast enhancement50. At 11 T, Goldhawk et al. (2009) saw increased R2 
relaxation rates and cellular iron uptake following MagA expression, though they noted that 
varying levels of MagA expression may lead to inhomogeneities in the MR signal. They also found 
signal void and blooming effect using MR to image the gut of mice fed an iron supplement49. We 
suggest that these hypointensities may be due to iron uptake by enterocytes as well as countless 
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gut microbes. Transgenic MagA-expressing mice have also been produced, with MagA expression 
verified in various tissues along with the presence of intracellular magnetosome-like particles61. 
Their findings supported the previous studies with increased R2 measurements in the MagA-
expressing transgenic mice61. Zurkiya et al. (2008) also found differences in 3-4 fold increases in 
MR transverse relaxation rates in MagA-expressing 293FT cells following iron supplementation58. 
If similar MR measurements were to be obtained in the context of our study, this would provide a 
great tool for imaging bacteria in vivo. 
 
1.4 Rationale 
Bacteria-human interactions tend to have a negative connotation, however many of these 
relationships are symbiotic. The benefits of microbiome interactions are complex and difficult to 
replicate outside of the host1. In the gut, this dependency of bacteria on their host varies depending 
on diet and micro-environment, which in turn influences gene expression2, metabolism and 
signaling pathways, providing an explanation for how the microbiome plays a role in disease2. It 
would therefore be beneficial to have a system for observing these interactions in situ. Establishing 
fast and safe protocols for visualizing the healthy gut microbiome in vivo will help clarify which 
factors play a role in disease manifestation and progression and enable better tools for early 
detection and treatment of dysbiosis.  
The current gold standard for gut microbiome investigation involves ex vivo analysis of microbial 
samples removed from the intestinal mucosa and attempts to propagate these in vitro for high-
throughput analyses, such as 16S rRNA to identify microbes and their relative abundance. 
Nevertheless, ex vivo samples are prone to contamination or changes in bacterial growth that may 
misrepresent the original sample. In addition, many microbes depend on bacterial-host interactions 
to survive, requiring specific nutrients or atmospheric conditions. Although there are model 
systems, including the chemostat fermenter1, it is impossible to recreate the complexity of the 
microbiome in vitro, therefore; these models should be used as a tool to validate in vivo techniques.  
We propose a complementary approach to ex vivo analyses, using in vivo imaging to observe 
bacterial growth, dispersion, and behaviour. Imaging also affords the potential for labeling bacteria 
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to improve sensitivity of detection. The research reported here provides a foundation for using 
MRI to image bacteria in vivo. Through this, we aim to foster a greater understanding of microbial 
behaviour, the microbiome, infection, and the personalized medicine required for early diagnosis 
and treatment of bacterial disease. 
 
1.5 Hypotheses 
Firstly, we hypothesized that MR relaxation rates vary among bacterial strains and species.  
Secondly, we hypothesized that MagA expression in Escherichia coli would increase cellular iron 
content and impart magnetic properties for cellular detection by MRI. 
 
1.6 Objectives 
To explore differences in MR measures between bacterial strains, we examined the MR 
relaxation rates of nine Escherichia coli strains along with their iron and manganese contents 
using inductively-coupled plasma mass spectrometry (ICP-MS). We then evaluated the 
relationships between these parameters as well as trends between MR measures, metal content 
and strain classification.  
To evaluate the effect of MagA expression on bacterial MR measures, we cloned epitope-tagged 
magA into an E. coli expression vector and transformed this MagA construct into E. coli 
BL21(DE3). MagA-expressing bacteria were assessed by immunoblotting to verify protein 
expression, by MRI to measure relaxation rates, and by ICP-MS to quantify total cellular iron 
and manganese content in the presence or absence of extracellular iron supplementation. 
To assess interspecies variability in MR measures and metal content, we obtained MR 
measurements for various bacterial species found in the urogenital tract and gut microbiome, 
relating these to iron and manganese content. We then explored the effect of iron acquisition 
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mutants on MRI and bacterial metal content. We also assessed the feasibility of distinguishing 
MR signatures in mixed samples of human bladder cells and Lactobacillus crispatus. 
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Chapter 2: Characterizing the magnetic resonance signal in 
different Escherichia coli strains with and without MagA expression 
 
2.1 Introduction 
Escherichia coli are gram negative, rod-shaped bacteria that commonly make up a relatively 
small percentage (approximately 0.1%) of the human gut microbiota1. Although E. coli only 
constitute a small portion of the microbial colonization, Gao et al. found that at least one or more 
strains of E. coli were present in each of the 148 human gut samples examined1, suggesting that 
E. coli are an integral component of the gut microbiome in most, if not all humans. Escherichia 
coli strains are not only important commensals in the human gut, but some are also pathogenic, 
causing major diarrheal, renal and other illnesses from intestinal invasion. In addition, E. coli is 
responsible for more than 80% of all urinary tract infections (UTIs), which are the most frequent 
infection in humans2. UTI recurrence can lead to chronic infection as well since E. coli can form 
and establish within biofilms, allowing the bacteria to become increasingly resistant to 
antibiotics, host defenses and shearing forces, thus promoting pathogen survival and colonization 
of the urinary tract3. Differential gene expression during biofilm formation may promote 
adherence to biological and abiotic surfaces4; however, some virulence factors that improve 
bacterial pathogenesis like type I pili and flagella are not crucial for biofilm formation4, 5.  
The ability of E. coli to acquire certain metal cofactors, such as iron, can also be considered a 
form of bacterial pathogenesis6. Iron uptake and storage is tightly regulated in E. coli and these 
regulatory mechanisms may be impacted by biofilm formation, bacteria-bacteria interactions or 
bacteria-host interactions. Low molecular weight, high-affinity iron chelators known as 
siderophores are commonly encoded on pathogenicity islands, genomic islands containing genes 
that contribute to bacterial virulence6. Ferritin and bacterioferritin store intracellular iron in E. 
coli in a readily available form for metabolic processes while preventing the iron from 
interacting with reactive oxygen species and causing cell damage and toxicity7. Intracellular iron 
in E. coli is stored in ferritin aggregates and soluble iron accounts for less than 1% of the total 
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cellular iron8. In iron-rich environments, the ferric uptake regulator (Fur) binds free iron, leading 
to transcriptional repression of iron uptake genes7, 9. Methods of iron uptake and storage in these 
bacteria are important as we consider using magnetic resonance imaging (MRI) for bacterial 
imaging, with the possibility of iron labelling for improved MR detection of bacteria. 
MRI is a non-invasive imaging modality with high spatial resolution and unrestricted depth of 
penetration for in vivo imaging. MRI is one of the most frequently employed clinical imaging 
modalities since it does not require the use of radioisotopes10, making it a safer alternative 
particularly for the young or pregnant population. Certain MR measurements are sensitive to 
magnetic field inhomogeneities caused by magnetic elements like iron11. These sensitivities can 
be exploited with contrast enhancement to improve target specificity10. Endogenous, gene-based 
agents provide long-term contrast and enable the monitoring of cellular activities12. Gene-based 
contrast has been previously demonstrated in mammalian cells by expressing single genes, such 
as magA12 or mms613. This has also been attempted in non-magnetic bacteria expressing full 
operons of magnetosome genes14 from environmental magnetotactic bacteria (MTB) to improve 
iron uptake and/or retention and impart magnetic properties. Here we focus on magA, which 
encodes a putative iron uptake protein that has previously been successfully expressed in E. 
coli15. This previous study found that MagA functioned as an ATP-dependent iron transporter on 
the inner membrane of E. coli and may be regulated by the Fur system15, 9 due to its innate 
repression in iron-rich conditions16. Many groups are trying to recreate the magnetosome by 
expressing magnetosome-associated genes in non-magnetic bacteria; however, magA is not 
conserved across all MTB. magA is not located on the genomic magnetosome island and is not 
essential for magnetosome formation17. Nevertheless, MagA expression in mammalian cells has 
been shown to increase cellular iron and transverse (R2, R2*) relaxivity12, 18. Though iron 
loading can be detrimental to cells and toxicity has been noted following high levels of MagA 
induction in some mammalian cells18, but not others12, 19, MagA-mediated toxicity in bacterial 
cells has yet to be reported and previous E. coli studies did not report toxic effects15. 
Here we sought to assess the MR relaxation rates of E. coli and examine the effect of MagA 
expression on MR measures. Due to high genetic intraspecies variability in E. coli20, we 
hypothesized that MR relaxation rates vary among E. coli strains and that expression of MagA in 
these bacteria would increase cellular iron content and impart magnetic properties for cellular 
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detection by MRI at clinical field strength. To explore differences in MR measures between 
bacterial strains, we examined the MR relaxation rates of various lab, commensal and 
uropathogenic E. coli along with their cellular iron and manganese contents. We evaluated the 
relationships between MR measures, elemental content and strain classification. We also 
evaluated the effect of MagA expression on bacterial MR measures by preparing a magA 
expression plasmid and transforming this construct in E. coli BL21(DE3). MagA expression was 
then assessed and related to MR relaxation rates and the cellular iron and manganese contents of 
cells cultured in the presence or absence of extracellular iron supplementation. 
 
2.2 Materials and Methods 
2.2.1 Reagents 
All reagents were from Thermo Fisher Scientific, Mississauga, Canada and Sigma-Aldrich, 
Oakville, Canada unless otherwise noted. 
2.2.2 Bacterial strains and culture conditions 
E. coli BL21(DE3) were grown in lysogeny broth (LB) for 20 h at 37°C with shaking. When 
transformed with pcDNA3.1MycHisA+/HA-magA, cells were grown in the presence of ampicillin 
(200 µg/mL). When transformed with a pET28a+ plasmid or a pET28a+/HA-magA-myc 
construct, cells were grown in the presence of kanamycin (30 µg/mL). Iron supplementation was 
achieved through addition of 40 µM FeCl3 to LB. To induce the expression of epitope-tagged 
HA-MagA-Myc, 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to cultures 
with an optical density at 600 nm (OD600) of approximately 0.6.  Induced cultures were then 
incubated at 30°C with shaking until harvest. All other E. coli strains (Table 2) were grown in 
LB for 16 h at 37°C with shaking. 
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Table 2. E. coli strains assessed in this study using MRI 
 
 
 
 
 
 
 
 
 
 
 
 
 
a All strains are untransformed unless otherwise indicated 
b UPEC, uropathogenic  
Straina            Classification             Plasmids 
MG1655 Commensal  
25922 Commensal  
Nissle Probiotic  
67 UPECb  
AD110 UPEC  
GR-12 UPEC  
536 UPEC  
J96 UPEC  
BL21(DE3) Lab  
BL21(DE3) Lab pET28a+ 
BL21(DE3) Lab pET28a+/HA-magA-myc 
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2.2.3 Cloning 
PCR amplification of HA-magA-myc 
Following overnight growth of E. coli BL21(DE3) / pcDNA3.1MycHisA+/HA-magA21 (Figure 2) 
in liquid culture, plasmid DNA was isolated and quantified by measuring A260/A280 using the 
DeNovix DS-11 Spectrophotometer (DeNovix, Wilmington, USA). The HA-magA-myc region of 
the plasmid was amplified by polymerase chain reaction (PCR) using custom primers (Table 3). 
Amplification upon adding 1 ng/µL or 10 ng/µL of pcDNA3.1MycHisA+/HA-magA was 
compared to a no template control. PCR reactions were completed using Phusion polymerase and 
a thermal cycler programmed with the following protocol: 1) 98°C 3 min, 2) 98°C 40 s, 3) 56°C 
35 s, 4) 72°C 90 s, repeating steps 2 – 4 for 33 cycles and ending with 72°C for 5 min. Amplified 
HA-magA-myc was purified using ENZA DNA purification columns, digested with NheI and 
XhoI restriction enzymes and column purified again. This insert was subsequently introduced 
into pET28a as described in the following section. 
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Figure 2. Vector map of pcDNA3.1MycHisA+/HA-magA. HA-magA was previously subcloned 
from pEGFP-C2 using BglII and BamHI and introduced into the BamHI site within the 
pcDNA3.1MycHisA+ vector. Adapted from Quiaoit (2015)21 using SnapGene 4.0 
  
pcDNA3.1MycHisA+/HA-magA 
6870 bp 
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Table 3. pET28a+/HA-magA-myc cloning primers 
Primer Sequence (5'-3') a 
Forward ATATATGCTAGCTACCCATACGACGTACC 
Reverse ATAATGCTCGAGTCATAGGTCCTCTTCTGAG 
a Bolded text refers to NheI (forward) and XhoI (reverse) restriction sites; red text in the reverse 
primer designates a stop codon; underlined text refers to HA (forward) or myc (reverse). 
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Generation of pET28a+/HA-magA-myc 
Cloning was achieved using a two-step process: first, in E. coli DH5α, we prepared and 
identified the HA-magA-myc insert from the pcDNA3.1MycHisA+ vector and subcloned it into 
our destination vector pET28a+ to form our MagA expression construct. We then shuttled our 
final MagA expression construct into BL21(DE3), an E. coli strain commonly used for 
expression experiments. 
pET28a+ was propagated in E. coli DH5α; plasmid DNA was isolated and digested with NheI 
and XhoI. Digested pET28a+ was then purified using an ENZA column. Alkaline phosphatase 
treatment was omitted as the digested ends were not compatible. 
NheI / XhoI digested HA-magA-myc and pET28a+ were ligated using an ~10:1 ratio of insert to 
vector. Ligation was performed at 16°C overnight using T4 DNA ligase. The pET28a+/HA-
magA-myc ligation product was added to chemically competent E. coli DH5α and transformed 
using the heat shock method22. Transformation reactions were plated on LB agar + kanamycin 
and grown overnight at 37°C. 
Transformants were picked and screened for the presence of HA-magA-myc by PCR, using the 
cloning primers described in Table 2 and Taq polymerase under the following conditions: 1) 
98°C 3 min, 2) 98°C 40 s, 3) 56°C 35 s, 4) 72°C 90 s, repeating steps 2 – 4 for 33 cycles and 
ending at 72°C for 5 min. In successfully transformed clones, the primers amplified HA-magA-
myc present in pET28a+ plasmid; PCR products were assessed by agarose gel electrophoresis. 
Positive colonies (containing the ~1.5 kb band) were grown in liquid culture and assessed by 
plasmid DNA isolation and restriction digestion with NheI and XhoI. The clone with the highest 
copy number displaying 5.3 kb and 1.5 kb bands by 1% agarose gel electrophoresis was chosen. 
pET28a+/HA-magA-myc from this clone was isolated and transformed into E. coli BL21(DE3), 
as was the empty vector, pET28a+. Several transformants were picked; plasmid DNA was 
isolated and digested with NheI / XhoI, NheI, SmaI, MluI, or MluI / XhoI to confirm successful 
transformation prior to sequencing. Clones with the highest copy number were pursued further. 
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Sequencing 
Clones of E. coli BL21(DE3) transformed with pET28a+ and pET28a+/HA-magA-myc (Figure 3) 
were sent for Sanger sequencing (Robarts Sequencing Facilities). The empty vector was assessed 
using the T7 forward primer, whereas pET28a+/HA-magA-myc was examined using custom 
primers (Table 4) to sequence over the full insert and part of the surrounding vector (Appendix 
3). 
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Figure 3. pET28a+/HA-magA-myc vector map. HA-magA-myc was cloned into pET28a+ at NheI 
and XhoI restriction sites. Plasmid maps were generated using SnapGene 4.0. IPTG induction leads 
to dissociation of the lac repressor, allowing T7 polymerase to initiate transcription 3' to the T7 
promoter. A species-specific ribosome binding site (RBS) is required to recruit the ribosome and 
allow for translation. The start codon (ATG) is 5' to tagged magA. His, T7 tag and HA epitope tags 
are found in frame 5' to magA, and a myc tag is encoded in frame 3' to magA. An in frame stop 
codon is encoded 3' to tagged magA, meaning that upon IPTG induction His-T7tag-HA-MagA-
Myc is expressed, allowing for detection of protein expression with commercial antibodies (see 
section 2.2.7). The kanamycin resistance gene (KanR) enables antibiotic selection for growth of 
transformed bacteria.  
pET28a+ / HA-magA-myc 
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Table 4. pET28a+/HA-magA-myc sequencing primers 
Primer Sequence (5'-3') 
MagA 2012 a GCGCTAAGACTGGAACGGTGGG 
MagA 5' internal b AAGAGCTTCACACCTTCTGC 
MagA 3' internal rev c GATTCCAGCACCAGCATCAT 
a Anneals at position 636 bp – 658 bp from the 5' end of magA, providing sequence of the 3' 
region, including magA, myc, His and the stop codon 
b Anneals at position 241 bp – 261 bp from the 5' end of magA for sequencing the middle of 
magA 
c Anneals at position 509 bp – 489 bp from the 5' end of magA on the antisense strand to 
sequence the 5' end of magA, HA, the start codon and ribosome binding site 
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2.2.4 Magnetic resonance imaging 
Sample preparation 
Escherichia coli were grown overnight as described in section 2.2.2. From these, 200 µL of each 
culture were placed in the wells of a 96-well plate to measure OD600 in the Eon Biotek plate 
reader (Biotek, Winooski, USA) equipped with Gen5 2.01 software. To obtain colony-forming 
unit (CFU) counts, the 200 µL cultures were serially diluted 1/10 down to 10-7 and 10 µL from 
each dilution was plated in triplicate on plates containing LB agar or LB agar + kanamycin. 
Plates were incubated aerobically at 37°C for 12 h before counting the number of CFUs. 
Equation 1 was used to calculate the total number of CFUs within the full culture based on the 
total culture volume and volume plated. 
Equation 1. 
Total CFUs   =    Average CFUs         * Total culture volume 
   Volume plated * Dilution factor 
The remaining culture was routinely pelleted at 4500 x g for 10 min; washed once with 35 mL 
phosphate-buffered saline (PBS, 154 mM NaCl / 2.7 mM KCl / 10 mM HPO4 pH 7.4) then twice 
with 10 mL PBS. Finally, cell pellets were resuspended in PBS to prepare a ~75% cell slurry for 
loading into Ultem wells (inner diameter: 4 mm, inner height: 9 mm, Lawson Imaging Prototype 
Lab) by centrifugation at 4500 x g for 10 min. Once full, total number of CFUs within the wells 
was estimated using Equation 2. Number of CFUs within the MR slice (see Figure 5) constitutes 
⅓ of the total CFUs loaded since slice thickness was 3 mm, the total inner height of the Ultem 
well was 9 mm and the wells were completely filled with bacteria. 
Equation 2. 
CFUs in well   =    Total CFUs      *  Volume loaded in well 
Total volume of cell pellet 
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Phantom preparation 
Cells were loaded into Ultem wells as described above prior to mounting in a 9 cm spherical MR 
phantom made of ~600 mL of 4% gelatin (porcine type A) / PBS (Figures 4 and 5)19. MR 
phantoms were scanned at 3 Tesla (3T) on a Biograph mMR (Siemens AG, Erlangen, Germany) 
adapting previously developed sequences to acquire longitudinal and transverse relaxation rates19 
as described below.  
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Figure 4. MRI cell phantom. Cells were loaded into Ultem wells by centrifugation at 4500 x g and 
then mounted in a spherical gelatin phantom (9 cm diameter). 
Marker Ultem wells 
4 % gelatin / PBS 
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Figure 5. Workflow for MR phantom preparation. Within 24 h of the scan, cells were loaded 
into Ultem wells (A) using centrifugation to create a compact pellet. Filled wells were then 
mounted on a solidified layer of 4 % gelatin / PBS (B) that partially filled one hemisphere of the 
spherical phantom. Once positioned, the wells were completely overlaid with gelatin / PBS (C) 
and allowed to set for 6 h at room temperature before transferring to 4°C overnight. To assemble 
the spherical phantom (D), one hemisphere containing only gelatin / PBS was taped to the sample-
filled hemisphere, separated by a double layer of parafilm to exclude air pockets. MR data was 
collected on a 3 T mMR Biograph. 
 
A B C D 
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MRI Sequences 
A slice thickness of 3 mm (Figure 6A) and field of view (FOV) of 120 x 120 mm2 was used for 
all image acquisitions.  
For R1 longitudinal relaxation rate acquisition, an inversion recovery (IR) spin echo sequence 
was used19. The matrix resolution was 128 × 128 mm2 and voxel size was 1.5 × 0.9 × 0.9 mm3. 
Repetition time (TR) was 4000 ms, flip angle was 90˚, and inversion times (TI) were 22, 200, 
500, 1000, 2000 and 3900 ms. IR scanning time was approximately 39 min. 
For R2 transverse relaxation rate measurements, a single-echo spin echo (SE) sequence was 
used. For R2* measurements, a multi-echo gradient echo sequence (GRE) sequence was 
employed19 (Figure 6B). The matrix resolution for both was 192 × 192 mm2 and voxel size was 
1.5 × 0.6 × 0.6 mm
3. For the SE sequence, echo times (TE) were 13, 20, 25, 30, 40, 60, 80, 100, 
150 and 200 ms; TR was 2010 ms; and flip angle was 90˚. SE scanning time was approximately 
61 minutes. For the GRE sequence, TE were 6.12, 14.64, 23.16, 31.68, 40.2, 50, 60, 70 and 79.9 
ms; TR was 200 ms; and flip angle was 60˚. GRE scanning time was approximately 25 minutes. 
Compared to a previous study by Sengupta et al. (2014), a larger slice thickness was used (3 mm 
vs 1.5 mm). In addition, echo times for SE sequences were shorter than those used for 
mammalian cells19 to accommodate the high transverse relaxivity of bacteria. 
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Figure 6. Representative slice and MR image. The MR signal was acquired from a 3 mm slice 
positioned perpendicular to each of the Ultem wells within a gelatin phantom, providing a cross 
section through the filled wells shown in two planes (A). Representative T2*-weighted multi-echo 
gradient echo imaging displays E. coli BL21(DE3) and LB/gelatin samples where the scale bar 
indicates signal intensity in arbitrary units. Shown here is the signal intensity at an echo time of 
31.86 ms (B). Data collected at multiple echo times are used to plot the change in signal intensity in 
a region of interest as a function of echo time. This provides the decay curve needed to calculate R2* 
(s-1). Numbers to the left of each well designate sample identity: 1 and 2 are LB / gelatin, 3 – 6 are 
BL21(DE3) either washed with PBS (3 and 4) or pelleted straight from LB (5 and 6), and 7 is the 
marker for orientation. 
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MR data analysis 
Longitudinal and transverse relaxation rates of samples were determined using custom software 
developed in Matlab 7.9.0 (R2010b). This software was used to select a 21-voxel region of 
interest (ROI) within the sample, avoiding the wall of the Ultem well. The average signal 
intensity within the ROI was determined at each TE or TI and decay curves were plotted using 
GraphPad Prism software, version 8.0.0, using a single exponential line of best fit (Appendix 6). 
R2' was calculated by subtraction (R2* - R2 = R2')11. Relaxation rates of replicate samples were 
reported as the mean +/- standard error of the mean (SEM) using GraphPad Prism software. 
A motion artifact appeared in approximately half of all images from GRE sequences. This 
motion always appears in the vertical/y-plane and was not caused by the physical movement of 
the gelatin phantom or any samples within. This apparent motion is likely attributed to MRI 
component malfunction requiring repair. To account for the vertical shift between TE’s, the 
position of ROI’s within each well was assessed at each TE and moved as necessary to ensure 
only sample would be contained within the ROI and not the edges of the Ultem well. 
2.2.5 Protein preparation and quantification 
For elemental iron quantification and western blot analysis, bacteria were cultured as above and 
pelleted at 4500 x g for 10 min at 20°C, washing three times with at least 10 mL PBS. Cell 
pellets were collected in radioimmunoprecipitation buffer (RIPA; 10 mM Tris-HCl pH 7.5/140 
mM NaCl/1% NP-40/1% sodium deoxycholate/0.1% sodium dodecyl sulfate) with Complete 
Mini protease inhibitor cocktail (Roche Diagnostic Systems, Laval, Canada). Cells were lysed 
through five cycles of freeze-thaw, then pelleted at 10,000 x g for 10 min to remove debris. 
Protein concentrations were calculated using the bicinchoninic acid (BCA) assay and bovine 
serum albumin (BSA) as the standard23. Absorbance at 562 nm was determined using the Eon 
Biotek plate reader and Gen5 2.01 software. 
2.2.6 Inductively-coupled plasma mass spectrometry 
For elemental iron and manganese analysis, samples containing 1 – 3 mg/ml of protein were 
prepared as indicated in section 2.2.5. Quantification of each element was performed using 
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inductively-coupled plasma mass spectrometry (ICP-MS, Biotron Analytical Services, Western 
University). Briefly, samples were digested using nitric acid and heat, then filtered prior to mass 
spectrometry. The data reported in this thesis reflect total cellular iron or manganese content 
normalized to total amount of protein.  
2.2.7 Examining MagA expression 
Protein separation 
Samples of total cellular protein described in section 2.2.5, were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS PAGE). Samples were assessed under reducing 
conditions using 0.71 M β-mercaptoethanol. Thirty micrograms of protein from each sample was 
separated based on protein size using a 5% stacking gel and 10% running gel. Molecular weight 
(M.W.) standards were used for size comparison. 
Western blot 
Protein separated by SDS PAGE was transferred to a nitrocellulose blot (iBlot Gel Transfer 
Stacks; BioRad, Hercules, USA) following the manufacturer’s protocol using the iBlot Gel 
Transfer Device and a 7 min transfer (BioRad). To block nonspecific binding, the blot was 
incubated in 10% Blotto/PBS for 3 – 5 h on a rocker at room temperature. To check for 
expression of the epitope-tagged MagA protein, the blot was incubated overnight at room 
temperature in 1:1000 rabbit anti-c-Myc / 2 % Blotto/PBS. Following the primary antibody 
incubation, blots were washed for 30 minutes with 3 changes of PBS / 0.05% Tween 20 (PBST), 
then incubated for 2 hours at room temperature with 1:20,000 horseradish peroxidase (HRP)-
conjugated goat anti-rabbit immunoglobulin/PBST. After the secondary antibody incubation, 
blots were washed for 30 minutes with three changes of PBST. Protein bands were developed 
using a Clarity MaxTM Western ECL Substrate (BioRad) and signal was detected under the 
ultraviolet transilluminator using the ChemiDoc® Imaging System (Syngene, Fredrick, USA). 
The estimated M.W. of His-T7-HA-MagA-Myc is 54 kDa.  
Level of MagA protein was compared to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
Blots were stripped in 245 mM β-mercaptoethanol / 2 % SDS / 62.5 mM tris-hydrochloric acid 
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(pH 6.8), washed in PBST, and re-probed as above, using 1:2000 rabbit anti-GAPDH as the 
primary antibody and 1:20,000 HRP-conjugated goat anti-rabbit immunoglobulin secondary 
antibody. GAPDH is approximately 37 kDa.  
MagA expression was also assessed using 1:2000 mouse anti-HA primary antibody paired with 
1:2000 HRP-conjugated goat anti-mouse immunoglobulin secondary antibody24. 
Coomassie Blue 
Following transfer of protein to nitrocellulose, protein remaining in the gel was stained using 
Coomassie blue. The gel was stained in 0.303 mM Coomassie blue / 10 % acetic acid / 25 % 
isopropanol for 1 h with rocking, then destained in 30.3 µM Coomassie / 10 % acetic acid / 10 % 
isopropanol for 1 h, then fixed in 10 % acetic acid for 72 h, changing the acetic acid until no 
more stain appeared in the fixative. The stained gel was washed with distilled water and then 
imaged under white light using the ChemiDoc® Imaging System (Syngene). 
2.2.8 Statistical analyses 
Statistical analyses were performed using GraphPad Prism version 8.0.0 and SPSS version 25. 
MR relaxation rates of bacteria were analyzed using one-way analysis of variance (ANOVA) 
where significance was defined at α = 0.05. Pearson’s correlations were assessed to determine 
the relationship between cellular iron content, manganese content, and MR relaxation rate. 
Multiple linear regression models were applied to examine correlations between measurements 
and trends in these measurements between E. coli strains. In these analyses, MR relaxation rate 
was the independent variable and iron and manganese content, strain designation and 
classification (lab, commensal or UPEC) were the dependent variables. 
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2.3 Results 
2.3.1 MR relaxation rates of E. coli BL21(DE3) 
Escherichia coli BL21(DE3) were cultured overnight in LB and either washed with PBS 
(BL21(DE3) / PBS) or left in LB (unwashed; BL21(DE3) / LB) prior to mounting in a cell 
phantom for MRI. Both longitudinal (R1) and transverse (R2*, R2) relaxation rates were 
examined and compared to the background signals from 4% gelatin / PBS (MR phantom 
background) and 4% gelatin / LB (bacterial culture background). As shown in Figure 7, MR 
relaxation rates did not vary between washed and unwashed E. coli, indicating minimal 
contribution to MR relaxivity from either PBS or LB. R1, R2 and R2* of BL21(DE3) were 
significantly higher than the gelatin or LB background (Figure 7; p < 0.001), with transverse 
relaxation rates of E. coli over 10 to 20-times higher than background. R1 of bacteria was 
increased approximately 4-fold over background (Appendix 1; p < 0.001).  
The irreversible (R2) component fully explained the total (R2*) transverse relaxation rate, with 
little to no contribution from the reversible (R2') component (R2' ~ 0; Figure 7). Raw MR data 
are available in Appendix 7. 
When BL21(DE3) cells were pelleted in Ultem wells at varying forces of gravity, there was little 
or no change in transverse relaxation rates (Figure 8A; n = 2 – 5). When normalized to CFUs, 
relaxation rates were similar between samples (approximately 4s-1/109 CFUs; Figure 7B), 
suggesting that the MR relaxation rates do not depend on these centrifugal speeds. We therefore 
assume that approximately the same number of cells were present in the imaged slice of each 
sample. 
  
  
51 
 
B
L
21
(D
E
3)
 / 
L
B
B
L
21
(D
E
3)
 / 
PB
S
G
el
at
in
 / 
L
B
G
el
at
in
 / 
PB
S
0
20
40
60
Relaxation
rate (1/s)
R1
R2*
R2
 
Figure 7. E. coli BL21(DE3) display high transverse relaxivity. The bar graph shows mean 
longitudinal and transverse relaxation rates for bacteria and/or the culture medium (n = 4 – 5). 
Cells were either pelleted from LB or after washing with PBS; then mounted in a cell phantom; 
and scanned at 3T. Data are the mean +/- SEM and were analyzed by one-way ANOVA and 
Tukey’s test. BL21(DE3) display significantly higher relaxation rates than gelatin/LB or the 
gelatin/PBS background (p < 0.001).  
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Figure 8. Relaxation rates of BL21(DE3) packed into wells at different relative centrifugal 
forces. Bar graphs show A) mean longitudinal and transverse relaxation rates, and B) mean 
relaxation rates per 109 colony-forming units +/- SEM for E. coli pelleted at various forces of 
gravity (n = 3 – 5, except n = 2 for gravity pelleted samples). 
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2.3.2 MR relaxation rates of various E. coli strains 
Various lab, probiotic, commensal and uropathogenic E. coli strains were cultured and mounted 
in a gelatin cell phantom for MRI. Transverse relaxation rates for E. coli Nissle, 25922 and 
AD110 were significantly lower than those of BL21(DE3), MG1655 and J96 (Figure 9; p < 
0.05). However, there was no overall trend within the classifications of strain type. There are 
strains on the higher and lower ends of the range (approximately 20 – 40 s-1) within each of the 
lab/probiotic/commensal/UPEC groupings. As noted for BL21(DE3), transverse relaxivity in 
these E. coli strains is dominated by the R2 component with little or no R2' contribution. 
These data show that transverse relaxation rates can vary widely between different strains of E. 
coli, irrespective of strain characteristics and origin (Figure 9; Table 2). The lower transverse 
relaxation rates of E. coli strains Nissle, 25922 and 67 indicate that these may be harder to detect 
than the other strains using SE and GRE sequences for MRI.  
Although longitudinal relaxation rates of E. coli strains 25922, AD110 and Nissle were 
significantly lower than some other strains (Table 5, p < 0.05), these MR measures showed little 
variation (1.22 – 1.88 s-1, Table 5). These data suggest that R1 measurements may not be a useful 
parameter for differentiating between E. coli strains in comparison to transverse relaxivity 
measurements. All raw MR data for E. coli strains are found in Appendix 8. 
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Figure 9. Escherichia coli are detectable by MRI. Bar graphs compare MR signals from the 
BL21(DE3) laboratory strain of E. coli with select probiotic (Nissle), commensal (MG1655, 
25922) and uropathogenic strains (67, AD110, GR-12, 536, J96). All E. coli exhibit relatively 
high transverse relaxation rates, with R2* consisting virtually entirely of an R2 component and 
little or no R2' contribution. One-way ANOVA indicates that R2/R2* of Nissle (light gray lines), 
25922 (dark gray lines) and AD110 (black lines) are significantly lower than various other tested 
strains (* p < 0.05). Data are the mean +/- SEM (n = 3 – 5). 
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Table 5. Longitudinal relaxation rates of E. coli strains 
E. coli strain R1 (s-1) # SEM (s-1) n 
BL21(DE3) a 1.70 d 0.06 5 
MG1655 b 1.66 bcd 0.07 3 
Nissle b 1.42 abc 0.07 3 
25922 b 1.22 a 0.08 3 
67 c 1.63 abcd 0.09 3 
AD110 c 1.31 ab 0.05 3 
GR-12 c 1.68 bcd 0.15 3 
536 c 1.64 abcd 0.09 3 
J96 c 1.88 d 0.09 3 
a Lab strain 
b Commensal or probiotic strain 
c Uropathogenic strain 
# Letters designate statistically significant differences in R1 values between E. coli strains where 
values followed by the same letter are not significantly different based on a one-way ANOVA 
and Tukey’s test (p < 0.05). 
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2.3.3 Fe and Mn quantification in E. coli strains 
Lysed samples from all E. coli strains imaged by MRI were examined by ICP-MS for 
quantification of ferromagnetic and paramagnetic metals like iron and manganese, respectively. 
When normalized to total cellular protein, total elemental iron content ranged between 0.34 to 
1.2 µg Fe / mg protein (Figure 10A). Only E. coli Nissle displayed significantly lower iron 
content than BL21(DE3) (Figure 10A; p < 0.05) and this difference in iron content was reflected 
in transverse relaxation rates (R2 of Nissle, 28.75 s-1 vs R2 of BL21(DE3), 43.36 s-1; Figure 9). 
Overall however, there was little or no correlation between total cellular iron content and R2 or 
R2* in these bacterial strains (Appendix 2), unlike mammalian cells19, 25. 
The manganese content of these same E. coli strains was approximately ten-fold lower than iron, 
ranging between 0.04 to 0.22 µg Mn / mg protein (Figure 10B). E. coli 536 sequestered more 
manganese than either BL21(DE3) or Nissle (p < 0.05), and E. coli 67 samples contained more 
Mn than over half of the other strains (Figure 10B; p < 0.05). Interestingly, UPEC strains tend to 
have higher manganese content than commensal or probiotic strains — UPEC have an average 
Mn content of 0.11 µg Mn / mg protein compared to 0.063 µg Mn / mg protein for the tested 
commensal or probiotic strains. This trend can be visualized by the grouping of UPEC 
manganese contents in comparison to non-UPEC strains, though sample sizes were not large 
enough to see any significant correlations (Appendix 2). Differences in iron and/or manganese 
content do not correlate with changes in MR relaxation rates, suggesting that other factors may 
be influencing MR measurements. All raw ICP-MS data for E. coli strains are found in Appendix 
9.  
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Figure 10. Content of iron and manganese varies between E. coli strains. Bar graphs display 
the variability in total cellular content of iron (A, blue) and manganese (B, red), with 
approximately 10-fold higher elemental iron than manganese in all strains. Despite variability in 
cellular iron content, Nissle displayed lower iron levels than BL21(DE3) (A). Manganese content 
is significantly higher in E. coli 536 (gray lines) than two other strains (536 vs. BL21(DE3), 536 
vs. Nissle). Likewise, manganese content is significantly higher in E. coli 67 (black lines) than 
several other strains (67 vs. BL21(DE3), 67 vs. Nissle, 67 vs. 25922, 67 vs. AD110, and 67 vs. 
GR-12). Data are the mean +/- SEM with points indicating individual samples (n = 3 – 6, * p < 
0.05).  
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2.3.4 Correlation between metal content and MR measures in E. coli 
strains 
Samples in which cells were analyzed both by MRI and ICP-MS provided paired Fe and Mn 
values for individual MR measurements. No correlation was found between iron content and R2 
(Appendix 2 A), though a weak correlation appeared between Fe and R2* (Appendix 2 C; p < 
0.05). Similarly, no correlation was evident between Mn and either R2 or R2* (Appendix 2 B 
and D). When separated into strain classification (lab, commensal/probiotic or UPEC), no 
correlations existed (Appendix 2). 
To further explore relationships between our measured parameters, we used a multiple linear 
regression model. Correlations between each parameter were assessed based on the Pearson 
correlation for comparisons between R2 or R2* and iron content, manganese content, as well as 
strain designation and classification (lab, commensal/probiotic or UPEC origin). There was a 
moderate positive correlation between R2 and iron or manganese content (r = 0.380 and 0.395 
respectively: Table 6, p < 0.05). Total cellular iron and manganese content were also moderately 
positively correlated (r = 0.522), indicating that E. coli samples with higher iron also contained 
higher manganese levels. R2 was moderately correlated to strain, demonstrating that there is a 
possibility of differentiating the identity of E. coli strains based on R2 measurements by MRI. As 
expected, strain identity and classification were moderately correlated (r = 0.465) (Table 6). R2* 
was also moderately positively correlated to manganese content (r = 0.375), but not iron content, 
and as in the R2 analysis, iron and manganese were moderately positively correlated, and strain 
identity and classification were moderately correlated. Interestingly, R2* had a stronger 
correlation to both strain identity and classification than R2 (r = 0.519 and 0.449 vs. r = 0.475 
and 0.360) meaning this MR measure may be slightly more sensitive to the distinction between 
commensal and pathogenic E. coli strains (Tables 6 and 7).  These data provide support for the 
notion of using MRI measurements as a method to differentiate E. coli strains (Table 7, p < 
0.001). 
Overall, the relationships between transverse relaxation rates and iron or manganese content 
indicate that there are more factors impacting transverse relaxivity besides these two metals, 
possibly including other paramagnetic elements and even the size and shape of bacterial cells.   
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Table 6.  Pearson correlationa of E. coli R2 measurements with iron, manganese, strain and 
classification. 
 R2 Fe Mn Strain b Classification c 
R2 1.000 0.380 * 0.395 * 0.475 ** 0.360 * 
Fe 0.380 * 1.000 0.522 ** 0.312 0.277 
Mn 0.395 * 0.522 ** 1.000 0.128 0.333 
Strain 0.475 ** 0.312 0.128 1.000 0.465 * 
Classification 0.360 * 0.277 0.333 0.465 * 1.000 
 
  
a Values for the Pearson correlation coefficient, r, range between weak (≤ 0.299) and moderate 
(0.300 - 0.699). 
b Separate E. coli strains were arbitrarily designated by a unique numerical value. 
c Classification was arbitrarily designated by a numerical value and refers to the category of 
bacterial strain: laboratory (designated 1), commensal/probiotic (2) or uropathogenic (3). 
Classifications of strains match up with axes on Figure 9 where BL21(DE3) is the lab strain. 
* p<0.05, ** p<0.01 
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Table 7.  Pearson correlationa of E. coli R2* measurements with iron, manganese, strain 
and classification. 
 R2* Fe Mn Strain b Classification c 
R2* 1.000 0.320 0.375 * 0.519 ** 0.449 * 
Fe 0.320  1.000 0.522 ** 0.312 0.277 
Mn 0.375 * 0.522 ** 1.000 0.128 0.333 
Strain 0.519 ** 0.312 0.128 1.000 0.465 * 
Classification 0.449 * 0.277 0.333 0.465 * 1.000 
 
 
a Values for the Pearson correlation coefficient, r, range between weak (≤ 0.299) and moderate 
(0.300 - 0.699)). 
b Separate E. coli strains were arbitrarily designated by a unique numerical value. 
c Classification was arbitrarily designated by a numerical value and refers to the category of 
bacterial strain: laboratory (designated 1), commensal/probiotic (2) or uropathogenic (3). 
Classifications of strains match up with axes on Figure 9 where BL21(DE3) is the lab strain. 
* p<0.05, ** p<0.01 
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2.3.5 MagA expression in E. coli BL21(DE3) 
Despite the relatively high transverse relaxivity of E. coli, we examined whether or not 
expression of a bacterial iron import protein would further increase the MR signal. To assess the 
impact of MagA expression on MR relaxation rates and iron content in E. coli, we transformed 
the BL21(DE3) laboratory strain with pET28a+/HA-magA-myc. Plasmid DNA was assessed by 
restriction digestion (Figure 11). Bacteria transformed with the empty vector served as a control 
for MagA expression. In addition to diagnostic digests, the successful preparation of 
pET28a+/HA-magA-myc and transformation into BL21(DE3) was confirmed by DNA 
sequencing. 
Expression of MagA in E. coli BL21(DE3) was assessed in the presence or absence of IPTG-
mediated protein induction. Coomassie Blue staining detected protein remaining in the gel after 
blotting and demonstrated that protein expression in BL21(DE3) was altered by the induction of 
MagA with IPTG (Appendix 4). Western blot analysis also shows altered protein expression in 
induced MagA-expressing cells compared to uninduced empty vector-containing cells, with an 
extra protein band at ~50kDa appearing in MagA-expressing E. coli (Figure 12). 
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Figure 11. Diagnostic digests of pET28a+/HA-magA-myc compared to empty vector. 
Diagnostic restriction digestion of pET28a+ with and without insert DNA confirms successful 
insertion of HA-magA-myc in the E. coli expression vector at NheI and XhoI restriction sites. 
Lanes 1 and 9 show the DNA ladder. Lanes 2 and 3 show empty vector either linearized with 
NheI (5369 bp) or doubly digested with MluI/XhoI (4404 bp, 965 bp), respectively. Lanes 4-8 
assess pET28a+/HA-magA-myc. The full-length construct in lane 4 was linearized with NheI 
(6745 bp). In lane 5, a double digest with NheI/XhoI retrieved the insert (1449 bp). Lane 6 
confirms that SmaI cuts internally to magA as well as within the vector (5676 bp, 972 bp). In lane 
7, MluI cut in the linker sequence between magA and myc, creating in an additional fragment in 
the MluI/XhoI digested hybrid construct (977 bp, 1364 bp, 4404 bp) compared to vector alone 
(lane 3). Lastly, in lane 8, BglII/XhoI appropriately cleaved pET28a+/HA-magA-myc (1619 bp, 
5126 bp) at sites surrounding the insert.  
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Figure 12. Western blot of MagA expression in E. coli BL21(DE3). Total protein from cells 
transformed with either empty vector or HA-MagA-Myc was separated by SDS-PAGE; 
transferred to a nitrocellulose blot; and probed with primary rabbit α-cMyc to detect Ha-MagA-
Myc protein levels. Molecular standards are shown on the left. Lane 1 contains uninduced cells 
harbouring the empty vector. Lane 2 contains induced cells harbouring the hybrid vector-MagA 
insert. Though there is non-specific binding in both lanes, we have provisionally identified a 
band in MagA-transformed E. coli between 40 – 50 kDa (red arrow), slightly below its estimated 
size of ~54 kDa.  
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2.3.6 Effect of MagA expression in E. coli BL21(DE3) on MR 
measures and content of metal ions 
We sought to elucidate the impact of MagA expression on E. coli MR relaxation rates and 
cellular iron content in the presence and absence of extracellular iron supplementation. In 
untransformed BL21(DE3), iron supplementation alone led to a small increase in transverse 
relaxivity (Figure 13A); however, this was not reflected in R2/R2* per billion CFUs (Figure 
13B), suggesting little or no influence of iron supplement on transverse relaxivity. Interestingly, 
MagA-transformed cells displayed lower transverse and longitudinal MR measures than 
untransformed cells +/- Fe, particularly upon induction of MagA expression (Figure 13A, 
Appendix 5). This drop in relaxivity may be due to lower viability of MagA-expressing cells 
(Figure 13B), indicating potential toxicity in these bacteria. Viability was assessed in terms of 
live CFUs loaded within the MR slice since CFU counts varied even as OD600 remained 
relatively constant since MagA expression increased cell turnover rather than slowing cell 
growth. 
Regardless of MagA expression or extracellular iron supplementation, there were no differences 
in total cellular iron content in E. coli BL21(DE3) (Figure 14A). However, manganese content 
decreased in MagA-expressing cells relative to controls (Figure 14B). These data show that 
manganese levels and R2/R2* fluctuate in a similar manner and may be proportional to bacterial 
viability. We suggest that the MagA-expressing cells import more iron per live cell than controls, 
leading to toxicity and cell death, while manganese content is not altered by MagA expression 
itself, but is decreased in MagA-expressing cells due to bacterial death. Dead but unlysed cells 
may be contributing to the MR signal in these MagA-expressing cells, leading to the lower, but 
still substantial MR signal (Figure 13A). Raw MR and ICP-MS data are displayed in Appendices 
10 and 11 respectively. 
Though Fe content appears to be constant and Mn decreases in MagA-expressing E. coli 
compared to controls, there are large differences in range of iron content vs. manganese content. 
We see a tighter range of data distribution and lower levels of manganese overall in comparison 
to iron, so although significant, the differences seen may not be biologically relevant. Though 
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many metal ion cofactors are present in small amounts, the effects of paramagnetic particles on 
MRI are orders of magnitude weaker than those by ferromagnetic particles26. 
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Figure 13. MagA expression does not improve MR detection of E. coli BL21(DE3) and 
diminishes cell viability. Bar graphs compare MR signals (A) or MR signal per billion live cells 
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(B) for BL21(DE3) before and after transformation with vector +/- MagA insert. Transverse 
relaxation rates were examined in the presence and absence of iron supplementation (+/- Fe) and 
MagA induction (+/- IPTG). One-way ANOVA indicates that untransformed, iron-supplemented 
cells exhibit higher transverse relaxation rates than their unsupplemented counterparts (light gray 
lines, ** p < 0.01). While the latter display higher R2/R2* than induced MagA-expressing cells 
(dark gray lines), in the presence of iron-supplementation, untransformed BL21(DE3) exhibit 
higher transverse relaxivity than all forms of MagA-transformed cells, regardless of protein 
induction or iron supplement (black lines) indicating that MRI of E. coli BL21(DE3) is not 
improved by MagA expression. MagA induction lowers R2/R2* in iron supplemented bacteria 
(dashed lines). After normalizing MR data to 109 CFUs (B), the signal from MagA-expressing 
cells decreases significantly as cell viability drops compared to untransformed and vector-
transformed controls (* p < 0.05). Data are the mean +/- SEM (n = 3 – 5). 
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Figure 14. Manganese, but not iron content varies in MagA-expressing E. coli BL21(DE3). 
Elemental iron content (A, blue bars) is unchanged by iron supplementation, transformation with 
a MagA construct, or induction of MagA expression; whereas, elemental manganese content (B, 
red bars) varies significantly. Total cellular manganese content is higher in the vector control 
than in MagA-expressing bacteria, regardless of iron supplementation (black lines, * p<0.05). In 
iron-supplemented MagA-transformed cells, manganese levels drop following induction of 
MagA (gray lines). Data are the mean +/- SEM (n = 3 – 6, except n = 2 for iron content of MagA 
+ Fe + IPTG).   
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2.4 Discussion 
In summary, we examined the MR relaxation rates of E. coli strains that may be encountered in 
the laboratory, the urinary tract or the gut and have different genomic compositions and outputs 
relating to survival in their particular niches. In the laboratory model, BL21(DE3) displayed high 
transverse relaxivity, much higher than that previously described in mammalian cell lines using 
the same MR sequences19, 21, 24. In addition, bacterial transverse relaxivity was predominantly an 
R2 signal, with little to no R2' contribution. As expected, the density at which bacterial cells 
were packed by centrifugation into phantom wells (at relatively low speeds < 4,500 x g) did not 
affect the MR measures normalized to CFUs. This is consistent with MR measures being 
proportional to the number of live cells within the imaged sample. Between E. coli strains, 
transverse relaxation rates varied, in part due to differences in iron and manganese content. 
However, there was little variation in longitudinal relaxivity between these bacterial strains. 
Though the MR measures did not distinguish between commensal or pathogenic groups, each 
strain exhibited a distinct MR signature. Finally, MagA expression in E. coli BL21(DE3) did not 
enhance MR measures or increase cellular iron content when cells were cultured in the presence 
of extracellular iron supplementation. The data are consistent with MagA-associated 
cytotoxicity. 
Interestingly, the baseline MR signature of E. coli BL21(DE3) exceeded that of mammalian 
cells, including those displaying contrast enhancement through MagA expression and 
extracellular iron supplementation19, 21, 24. The high bacterial transverse relaxivity may be useful 
in differentiating the MR signal of bacteria from human tissue and provides a potentially 
important foundation for future studies using in vivo MRI to observe bacterial-host interactions. 
The lack of R2′ component for transverse relaxivity (i.e. R2 ~ R2*) in all E. coli strains is also 
interesting. Previous literature reporting that 99% of all intracellular iron in E. coli is stored in 
protein aggregates to prevent interactions with reactive oxygen species that may damage the 
cell7, 8. Perhaps the different components of transverse relaxivity are impacted differentially by 
the form of iron within the cell. In our samples R2 appears to be greater than R2*, however this 
is inconsistent with the definition of R2*. This discrepancy may have arisen because different 
pulse sequences were used to make independent R2 and R2* measurements, each potentially 
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propagating some systematic errors.  For example, flip angles errors in the SE sequence may 
have led to some loss of signal in the transverse plane, consequently decreasing T2 and 
increasing R2 measurements. Additionally, the echo-spacing in the multi-echo GRE sequence 
used in this study could have influenced the T2* measurement leading to a higher T2* time 
constant, and consequently a lower R2* value. Further refinement of our MR sequence 
parameters for bacterial detection are warranted. Although these systematic errors are worth 
noting, they do not impact on the main findings of this study as we focus on the comparison of 
transverse relaxivity measurements between bacteria and not their absolute relaxivity values.  
Our data normalizing bacterial MR measures to CFUs raise the possibility that intrastrain 
variation in MR relaxivity may be influenced by bacterial viability, but future experiments would 
require a range of bacterial dilutions to accurately explore this relationship. It may also be 
beneficial to saturate the bacteria in an MR sensitive metal like iron or manganese to assess 
whether increased metal loading can improve bacterial detection when administered at sublethal 
levels. In addition, it would be interesting to assess MR measures in serially diluted bacterial 
samples to further explore the correlation between R2/R2* and number of CFUs, and better 
understand the threshold for bacterial detection. For example, the PET probe 6-[18F]-
fluoromaltose has a sensitivity down to 106 CFUs in vivo27, suggesting it may detect bacteria at 
the clinical threshold for most infections. In this study, Gowrishankar et al. (2014) administered 
radioactive probe to detect bacteria in vitro in mammalian cells as well as in vivo in a murine 
myositis model using both PET and bioluminescence imaging27. For our study, we imaged 
bacteria alone, assessing baseline MR signals as well as an endogenous gene-based probe 
(MagA) to improve imaging sensitivity. While MagA expression offered no advantage in a 
laboratory model, most E. coli strains examined had inherently high R2. 
Multiple linear regression analyses showed that variations in transverse MR measures between 
strains of E. coli are partially due to total cellular iron and manganese content. In addition to the 
influence of these elements on the proton signal, other factors may affect MR measures. Though 
all E. coli are rod shaped, there is some strain to strain size variation28 and even intrastrain size 
variation29. Differences in iron acquisition genes and metabolic needs of strains may explain 
variability in cellular iron content since, as discussed in section 2.1, iron acquisition genes are 
virulence factors contributing to bacterial pathogenesis. For example, certain UPEC encode 
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siderophores such as salmochelin and aerobactin on their pathogenicity islands to improve 
survival in low iron environments6. Iron and manganese uptake are linked in UPEC expressing 
the sitABCD operon within their pathogenicity island(s)30. The genes in this operon include 
those encoding iron and manganese uptake proteins that are regulated by transcription factors 
involved in the Fur system as well as the MntR manganese regulator31. The combined regulation 
of iron and manganese uptake and enormous genetic intrastrain variability supports the similarity 
in trends between iron and manganese content in UPEC strains, but not necessarily the lab or 
commensal E. coli strains. Interstrain variation in MR measures may also be impacted by other 
magnetic or paramagnetic atoms that were not examined in this study. Not all atoms create 
identical local magnetic fields, meaning some compounds will have a greater impact on MRI 
than others26. 
Total cellular iron content is positively correlated to transverse relaxation rates in iron-
supplemented MagA-expressing mammalian cells19, 24, 25; therefore, we examined whether 
expression of the MTB putative iron transporter, MagA, in non-magnetic bacteria might further 
improve MR relaxivity. In our BL21(DE3) expression system this was not the case. Upon IPTG-
induction, MagA-expressing cells displayed decreased viability, especially upon iron 
supplementation.  Iron is tightly regulated in E. coli to prevent toxicity7 so our data suggest that 
the reduced viability observed following MagA expression may be due to MagA-related iron 
toxicity. Unlike MTB which contain intracellular vesicles (magnetosomes) for dedicated iron 
storage, E. coli are innately non-magnetic. The possibility of imparting magnetic properties to 
non-magnetic bacteria was previously demonstrated in Rhodospirillum rubrum, by incorporating 
several operons containing approximately 30 magnetosome genes to produce relatively 
functional magnetosome-like iron biominerals14. The notion of creating magnetosome-like 
nanoparticles in mammalian cells using single gene expression systems has been partially 
successful, perhaps because iron may be sequestered within intracellular vesicles in eukaryotes. 
Nevertheless, MagA expression has given variable results in different mammalian cell types, 
suggesting that single MTB gene expression systems fall short of creating the optimal 
magnetosome-like compartment and may increase the risk of cytotoxicity18, 32. A previous study 
expressing MagA in E. coli DH5α did not report toxic effects15; these cells were grown in 
unsupplemented LB before isolating magnetosome-like particles and subjecting these “vesicles” 
to 330 µM ferrous ammonium sulfate for iron loading. We recorded cytotoxicity in MagA-
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expressing BL21(DE3) cultures growing in either LB alone or LB supplemented with 40 µM 
ferric chloride. While variable tolerance for MagA activity among different E. coli strains is a 
possibility, Nakamura et al. (1995) did not report cell growth characteristics in the presence and 
absence of MagA expression. Their use of the trc promoter suggests that there would be high 
basal transcription by the leaky promoter, though the T7 promoter we used has been shown to 
cause higher protein expression than the trc system33. Our MagA construct enabled us to induce 
protein expression, but we were unable to repress expression for more stringent regulation. 
Tighter regulation of MagA expression may allow us to repress MagA transcription during initial 
growth phases, then induce expression and cause iron loading as the culture reaches the plateau 
phase, enabling bacterial proliferation and iron loading through MagA expression.  
 
2.5 Conclusions 
In this study, we assessed the MR relaxation rates of various E. coli strains and examined the 
effect of MagA expression on MR measures in a model laboratory bacterium. We found that 
each E. coli strain had its own MR signature; however, MRI alone was not enough to distinguish 
between lab, commensal or uropathogenic groups. Potentially, MR signal(s) in combination with 
the analysis of cellular iron and/or manganese content could be used to identify these groups of 
bacteria. We created a MagA-expressing E. coli strain and found that, regardless of iron 
supplementation, MagA expression reduced cell viability, thereby reducing MR relaxation rates, 
cellular manganese content and bacterial detection by MRI. Overall, our findings suggest that 
tracking bacteria using MRI is feasible and that future applications or improvements in MR 
detection may not require any form of contrast enhancement for in vivo bacterial detection within 
the human host. 
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Chapter 3: In vitro characterisation of the magnetic resonance signal 
of  Lactobacillus crispatus and other urinary bacterial isolates  
 
3.1 Introduction 
Bacterial-host interactions are widespread and many of these are complex symbiotic relationships 
as in the human microbiota at different sites in the human body. A microbiota is a community of 
microorganisms that interact with each other and their host to thrive. The interactions between 
microbes and their host cause changes in metabolism and signaling pathways, providing an 
explanation for how the microbiota plays a role in disease1. Having a “healthy” microbiota has 
been shown to protect us from pathogens, produce metabolites for energy and play a major part in 
homeostasis, amongst other functions2. Unfortunately, microbiome interactions are complex and 
difficult to replicate outside of the host2. 
The current gold standard for microbiota analyses involves ex vivo analysis, by removing microbial 
samples from the mucosa and attempting to propagate these in vitro for high-throughput analyses, 
such as 16S rRNA analysis, shotgun metagenomics or metabolomics to identify the microbes, their 
properties and functions. However, these samples may become degraded, contaminated, or 
undergo changes in bacterial growth that render them unrepresentative of the original sample. For 
example, the microbiota within feces versus the intestinal mucosa or other sites along the 
gastrointestinal tract can differ in both bacterial diversity and abundance3, 4. Many microbes 
depend on bacterial-host interactions, specific nutrient requirements and atmospheric conditions 
to survive, making them difficult to culture ex vivo. Although there are model systems for complex 
cultures, including the artificial human gut/chemostat fermenters2, it is impossible to fully recreate 
the complexity of the microbiome in vitro, therefore, these methods should be used as tools to 
validate in vivo techniques. Chemostat systems are reproducible and cost-effective alternatives to 
in vivo studies, but reports have found variation in same-donor between-run repeatability as well 
as discrepancies in the composition of fecal inocula compared to chemostat culture. Additionally, 
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over 30 days may be required to achieve a stable community2, in which time in vivo techniques 
could have already been performed and treatment initiated.  
Given the importance of the microbiota on human health, it is critical to establish ways to visualize 
the microbiota in healthy and disease states in vivo, to complement the current ex vivo analyses 
and to elucidate the factors involved in disease manifestation and progression in real time. In the 
future, this may be achieved with imaging tools such as magnetic resonance imaging (MRI) to 
detect and identify microbes. The utility of advanced imaging techniques for microbiome research 
is exemplified by a recent microscopy study using fluorescence in situ hybridization (FISH)5. Prior 
to this study, it was believed that gut bacteria were dispersed in microcolonies but, through imaging 
gnotobiotic mice with FISH, it was observed that the gut microbiota is very dynamic, with rapid 
turnover and cellular shedding preventing aggregations and leading to more homogeneous 
bacterial dispersion5. There are also many groups exploring the potential applications of positron 
emission tomography (PET)6 and ultrasound7 to visualize the presence and dispersion of specific 
bacteria within the microbiota. There is still much to learn in microbiome research and 
complementing ex vivo analyses with in vivo imaging may be beneficial for observing bacterial 
growth, dispersion and behaviour in their preferred niche, as these properties are not well-studied 
in either health or disease.  
While modalities like MRI are widely applied clinically, currently very little research has 
employed this technology to specifically detect bacteria8, 9. There are a multitude of MRI studies 
imaging bacterial infection indirectly by focusing on inflammation10, 11. Assuming bacteria can be 
detected at clinically relevant levels using MRI, the question remains whether the bacterial 
magnetic resonance (MR) signal can be resolved from that of surrounding mammalian tissues 
based on distinct differences in cellular relaxation rates, individual cell characteristics and 
diffusion. Does et al (2002) used 4.7 Tesla MRI to resolve three distinct microenvironments within 
the rat trigeminal nerve in vivo based on a combination of T1 and T212. Using these data and 
theoretical physics, others suggest that if the difference in MR relaxivity between two components 
is great enough, separation of the MR signatures may be possible13-15. We hypothesize that 
differences in MR signatures of different cell types may be partially due to differences in 
intracellular MR-sensitive metal concentrations such as iron and manganese. 
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Ferromagnetic and paramagnetic metals like iron, manganese, nickel, cobalt, gadolinium, and 
dysprosium influence MRI. The association of various bacterial types with metals in the 
environment and in medicine has long been investigated16-18. Bacterial acquisition of metal 
cofactors, like iron and manganese is widely considered a form of bacterial pathogenesis with 
many siderophores encoded on pathogenicity islands to improve survival in low iron 
environments19, 20. Ferritin and bacterioferritin store intracellular iron for use in metabolic 
processes in bacteria while preventing the iron from interacting with reactive oxygen species and 
causing cell damage and toxicity21. In iron-rich environments, the ferric uptake regulator (Fur) 
binds free iron, leading to transcriptional repression of iron uptake genes21, 22. Iron and manganese 
uptake are linked in gram-negative uropathogenic Escherichia coli (UPEC) expressing the 
sitABCD operon within their pathogenicity island(s)23. The genes in this operon include those 
encoding iron and manganese uptake proteins that are regulated by transcription factors involved 
in the Fur system, as well as the MntR manganese regulator24. In Staphylococcus aureus, iron 
acquisition is facilitated mainly through the isd genes to obtain iron in the form of heme, as well 
as the Fe3+ siderophore system. Staphyloferrin A (sfa) is one of the siderophores produced by 
Staphylococcus spp. that is regulated by Fur25. This siderophore is encoded by the sfaABC operon 
and sfaD, and though mutation of this locus prevents staphyloferrin A production, bacterial growth 
is unaltered due to redundancy in iron acquisition26. Staphyloferrin B is encoded by the siderophore 
biosynthesis (sbn) operon, and unlike sfa, mutations in sbn lead to impaired bacterial iron 
acquisition and growth26. Deletion of both sfa and sbn leads to severely impaired growth in iron 
deplete conditions where active iron uptake by siderophores is crucial, but in iron replete 
conditions, growth of siderophore mutants is recovered26. Unlike many other bacteria, lactobacilli 
do not use iron as a cofactor; instead they rely on manganese27, 28. In general, lactobacilli actively 
import manganese using the MntA manganese/cadmium transporter29, 30 for downstream uses in 
activating enzymes like lactate dehydrogenase and RNA polymerase31. Both bacterial acquisition 
and storage of paramagnetic metals like iron and manganese are important factors to consider when 
using MRI for bacterial imaging. 
Our research group is mostly interested in the urological system. The most frequent infection of 
humans is urinary tract infections, where the main aeitiological agent responsible is E. coli. 
However, in healthy individuals, the lower urinary system is dominated by species of lactobacilli 
and most frequently, members of the Lactobacillus crispatus species. While the microbiota of the 
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urinary system is slightly more complex than the absence or presence of these commensal bacteria 
in health or disease, it represents a much simpler microbiota than that of other sites in the body, 
with lower microbial diversity and reasonable densities, enabling more rapid human studies in this 
area. Here, we sought to assess the MR relaxation rates of various pathogenic and commensal 
urinary isolates and to explore the bacterial detection limit using MR measures. In addition, we 
examined how mixed bacterial/mammalian cell samples may impact MR measures and potentially 
alter individual bacterial MR signatures. Due to large genetic variability and differences in iron 
and manganese handling31, we hypothesized that MR relaxation rates vary drastically between 
bacterial species. We also suggested that bacteria with higher cellular iron or manganese content 
would have higher MR relaxation rates and therefore be easier to detect by MRI at clinical field 
strength. To explore differences in MR measures between urinary bacterial isolates, we examined 
the MR relaxation rates of various probiotic, commensal and uropathogenic bacteria along with 
their iron and manganese content. In addition, we related bacterial counts to MR measures and 
assessed the feasibility of distinguishing MR signatures in mixed samples of human bladder cells 
and L. crispatus. Finally, we explored the effect of iron acquisition mutants on cellular MRI and 
metal content. 
 
3.2 Materials and Methods 
3.2.1 Reagents 
All reagents were from Thermo Fisher Scientific, Mississauga, Canada and Sigma-Aldrich, 
Oakville, Canada unless otherwise noted. 
3.2.2 Bacterial strains and culture conditions 
Escherichia coli BL21(DE3) was grown in LB for 20 h at 37°C with shaking. Staphylococci 
were grown in Brain-Heart Infusion (BHI) broth for 16 h at 37°C with shaking, or, when noted, 
in iron deplete RPMI-1640 medium for 24 h at 37°C with shaking. Pseudomonas aeruginosa 
PA01 was grown in LB for 16 h at 37°C with shaking. All lactobacilli were grown in deMan, 
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Rogosa and Sharpe (MRS) broth anaerobically for 24 h at 37°C. Proteus mirabilis 296 and 
Klebsiella pneumoniae 280 were grown in LB, while Enterococcus faecalis ATCC33186 was 
grown in BHI, all anaerobically for 24 h at 37°C.  
3.2.3 Tissue culture conditions 
Human bladder epithelial cells (ATCC 5637) were cultured in RPMI-1640 containing 10% FBS 
and 4 U/mL penicillin/4 μg/mL streptomycin at 37°C in 5% CO2. For passaging or amplification, 
plates were washed twice with PBS then cells were agitated in 0.05% trypsin / 
ethylenediaminetetraacetic acid and incubated at 37°C for 10 min before removing cells. Cells 
were pelleted at 550 x g for 10 min at 10°C then washed with PBS and resuspended in fresh 
media for plating. 
3.2.4 Magnetic resonance imaging 
Bacterial sample preparation 
After bacteria were grown overnight as described in section 3.2.2, 200 µL of each culture was 
placed in a 96-well plate and measured in an Eon BioTek plate reader (Biotek, Winooski, USA) 
with Gen5 2.01 software to obtain OD600 measurements. This aliquot of each culture was then 
serially diluted 1/10 down to 10-7 and 10 µL volumes were plated in triplicate on LB/agar or 
BHI/agar. Proteus mirabilis samples were always plated on 6% non-swarming LB/agar. For 
lactobacilli, 5 µL of each dilution was plated in triplicate on pre-warmed MRS/agar plates. After 
drying, plates were inverted and incubated either aerobically or anaerobically (depending on the 
bacterium) at 37°C for 12–24 h before counting the number of CFUs. Equation 1 (Chapter 2) 
was used to calculate the total number of CFUs within the full culture based on the total culture 
volume and volume plated. 
The remaining culture was routinely pelleted at 4500 x g for 10 min, washed once with 35 mL 
PBS then twice with 10 mL PBS. Finally, cell pellets were resuspended in PBS to prepare a 
~75% cell slurry and loaded into Ultem wells by centrifugation at 4500 x g for 10 min. 
Supernatant was removed and more cells were added and centrifuged until the Ultem well was 
full. Total number of CFUs within the wells were estimated using Equation 2 (Chapter 2) based 
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on CFU counts. The number of CFUs within the MR slice (see Figure 15) constitute ⅓ of the 
total CFUs loaded within the well, since slice thickness was 3 mm and the total inner height of 
the Ultem well was 9 mm. 
For L. crispatus dilutions, cells were cultured and quantified as described above but final cell 
pellets were diluted 1/2 in 4 % gelatin / PBS before serially diluting 1/2 down to a final dilution 
of 1/32. Diluted cells were mixed gently; loaded into Ultem wells; and immediately placed at 
4°C to solidify before mounting in the gelatin phantom. 
Sample preparation of bladder cells mixed with L. crispatus 
Human ATCC 5637 bladder cells were cultured as per section 3.2.3 in 12 x 150 mm plates;  
harvested; and combined into one sample for the serial dilutions described below. For harvesting, 
plates were washed twice with PBS, incubated with 0.05% trypsin/ethylenediaminetetracetic acid 
for 10 min, then cells were collected in a 50 mL conical tube. Cells were pelleted at 550 x g at 
10°C for 10 min then washed three times with PBS before obtaining cell counts using 
hemacytometry. Lactobacillus crispatus ATCC33820 were collected as described above 
(subsection on bacterial sample preparation, section 3.2.4) including plating for cell counts. A 
suspension of L. crispatus was serially diluted ½ with a suspension of bladder cells using the 
following ratios of mammalian:bacterial cells (v/v): 15:1 (93.75%/6.25%), 7:1 (87.5%/12.5%), 
3:1(75%/25%) and 1:1 (50%/50%). Samples of bladder cells alone were also prepared for MR 
analysis. Two biological replicates at each ratio were loaded into Ultem wells by centrifugation 
at 550 x g; removing supernatant and loading more sample until wells were full of the cellular 
mixture. Total number of bladder cells as well as bacterial cells were calculated as per Equation 
2 (Chapter 2), factoring in the ratio of each cell type. 
Phantom preparation 
Cells were loaded into Ultem wells prior to mounting in a 9 cm spherical MR phantom made of 
4% gelatin (porcine type A)/PBS (Figures 4 and 5 in Chapter 2). MR phantoms were scanned at 
3T on a Biograph mMR (Siemens AG, Erlangen, Germany), adapting previously developed 
sequences32 to acquire longitudinal and transverse relaxation rates, as described below.  
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MRI Sequences 
A slice thickness of 3 mm (Figure 15A) and field of view (FOV) of 120 x 120 mm was used for 
all image acquisitions. 
An inversion recovery (IR) spin echo sequence was used to acquire R1 measurements. Matrix 
resolution was 128 × 128 mm2 and voxel size was 1.5 × 0.9 × 0.9 mm3. Repetition time (TR) was 
4000 ms, flip angle was 90˚, and inversion times (TI) were 22, 200, 500, 1000, 2000 and 3900 
ms. 
For R2 transverse relaxation rate measurements, a single echo spin echo (SE) sequence was used 
(Figure 15B) and a multi-echo gradient echo (GRE) sequence for R2* measurements. The matrix 
resolution for both sequences was 192 × 192 mm2 and voxel size was 1.5 × 0.6 × 0.6 mm3. For 
SE spin echo, measurements were obtained at echo times (TE) 13, 20, 25, 30, 40, 60, 80, 100, 
150 and 200 ms; TR was 2010 ms; and flip angle was 90˚. Scanning time took approximately 61 
minutes. For the GRE sequence, measurements were obtained at TE 6.12, 14.64, 23.16, 31.68, 
40.2, 50, 60, 70 and 79.9 ms; TR was 200 ms; and flip angle was 60˚.   
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Figure 15. Representative slice and MR image. The MR signal was acquired from a 3 mm slice through 
the wells of a gelatin phantom where the cross-section through the samples is shown in two planes (A). 
Representative T2-weighted spin echo imaging displays an array of serially diluted L. crispatus 
ATCC33820 samples where the scale bar indicates signal intensity at the specified echo time (B). 
Changes in signal intensity over echo time are plotted to obtain R2 values. Numbers to the left of each 
well designate sample identity: 1 is the marker for orientation; 2, 6 and 10 are 1/2 dilutions of L. crispatus 
in gelatin; 3, 7 and 11 are 1/4 dilutions of L. crispatus in gelatin; 4, 8 and 12 are 1/8 dilutions of L. 
crispatus in gelatin; 5, 9 and 13 are 1/16 dilutions of L. crispatus in gelatin; 14 contains Staphylococcus 
aureus USA300; 15 contains the double deletion mutant of S. aureus USA300 Δsfa/Δsbn; 16 is the triple 
deletion mutant of S. aureus USA300 Δsfa/Δsbn/ΔftnA; 17 contains transformed E. coli 
BL21(DE3)/pET28a+; 18 contains iron-supplemented E. coli BL21(DE3)/pET28a+. 
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MR data analysis 
Longitudinal and transverse relaxation rates were determined using custom software developed 
in Matlab 7.9.0 (R2010b). This software was used to select a 21-voxel ROI within the sample, 
avoiding the wall of the Ultem well. Signal intensity within the ROI was determined at each TE 
or TI and decay curves were plotted using Prism software (GraphPad; San Diego, CA) version 
8.0.0, and a single exponential line of best fit (Appendix 6). R2′ was calculated by subtraction 
(R2* - R2 = R2'). Relaxation rates were reported as the mean +/- SEM using Prism software. 
A  motion artifact appeared in approximately half of all images from GRE sequences. This 
motion always appears in the vertical/y-plane and was not caused by the physical movement of 
the gelatin phantom or any samples within. This apparent motion is likely attributed to MRI 
component malfunction requiring repair. To account for the vertical shift between TE’s, the 
position of ROI’s within each well was assessed at each TE and moved as necessary to ensure 
only sample would be contained within the ROI and not the edges of the Ultem well. 
Post-scanning viability assessment 
To qualitatively assess the viability of bacterial pellets following MRI, we used the 
LIVE/DEAD™ BacLight™ Bacterial Viability Kit and fluorescence microscopy. Approximately 
half of the cell pellet within the Ultem well was resuspended in 5 mL of PBS. In a separate tube, 
1.5 µL reagent A (SYTO 9) and 1.5 µL reagent B (propidium iodide) were diluted in 1 mL 
sterile distilled water. Then, 500 µL of each resuspended sample was mixed with 100 µL of 
diluted reagents A + B and incubated at room temperature for 15 min in the dark. Cells were 
centrifuged at 12,000 x g for 5 min to remove the supernatant and cell pellets were washed with 
PBS to remove unbound dye. Stained samples were diluted in PBS as necessary and 5 µL was 
loaded onto slides with mounting oil and coverslips. Slides were examined by fluorescence 
microscopy on a Zeiss Axioskop (Carl Zeiss AG, Oberkochen, Germany) with a FluoArc HBO 
100 (Carl Zeiss AG) fluorescence illumination system, using the Texas red filter (excitation 596 
nm / emission 615 nm) to visualize dead cells (stained with propidium iodide) and the FITC filter 
(excitation 495 nm / emission 519 nm) for SYTO 9 labelling of live cells. To obtain semi-
quantitative data, relative proportions of live to dead cells were estimated by manually counting 
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the number of dead cells over at least three separate fields of view containing ~100 - 500 cells 
per FOV. 
3.2.5 Protein preparation and quantification 
For elemental iron quantification, bacteria were cultured as above and centrifuged at 4500 x g for 
10 min at 20°C,  washing three times with at least 10 mL PBS. Cell pellets were collected in 
RIPA buffer with Complete Mini protease inhibitor cocktail (Roche Diagnostic Systems, Laval, 
Canada) and lysed through five cycles of freeze-thaw. Protein concentrations were calculated 
using the BCA assay and BSA as the standard33. Absorbance at 562 nm was determined using 
the Eon plate reader. 
3.2.6 Inductively-coupled plasma mass spectrometry 
For elemental iron and manganese analysis, samples containing 1–3 mg/mL of protein were 
prepared as indicated in section 3.2.5. Quantitation was performed using ICP-MS (Biotron 
Analytical Services, Western University). Briefly, samples were digested using nitric acid and 
heat, then filtered prior to mass spectrometry. The data reported here reflect total cellular iron or 
manganese content normalized to total amount of protein.  
3.2.7 Statistical analyses 
Statistical analyses were performed using Prism software and SPSS version 25. MR relaxation 
rates and metal contents of bacteria were analyzed using one-way ANOVA, where significance 
was defined at α = 0.05, and followed by Tukey’s test. Kruskal-Wallis multiple comparisons test 
was performed on ICP-MS data of bacterial species since these data were non-parametric. 
R2/R2* ratio comparisons were achieved using the unpaired Mann-Whitney test to compensate 
for large differences in sample size between groups. 
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3.3 Results 
3.3.1 MR relaxation rates of examined bacteria 
Various commensal, probiotic and pathogenic bacteria were cultured and subjected to MRI. 
Transverse relaxation rates of L. gasseri  ATCC33323 were significantly higher than all other 
species examined (Figure 16A and B; p < 0.001). Lactobacillus rhamnosus GR-1 displayed 
higher transverse relaxivity than L. reuteri RC14, with higher R2 than P. mirabilis 296 and S. 
aureus Newman as well (Figure 16 A and B; p < 0.05). Proteus mirabilis 296 and S. aureus 
Newman displayed low transverse relaxivity (Figure 16 A and B). Multiple Lactobacillus spp. 
demonstrated high transverse relaxation rates, with the signal intensity of L. crispatus 
ATCC33820 decaying before the first TE (13 ms), meaning the signal from these wells was 
much lower than other samples at TE = 13 ms and did not decrease further at higher TE, and thus 
preventing an accurate measurement (data not shown).   
Longitudinal relaxation rates of L. rhamnosus GR-1 were significantly higher than all other non-
lactobacilli examined (Table 8, p < 0.01). Lactobacillus gasseri ATCC33323 displayed higher 
R1 than all non-lactobacilli except for E. faecalis 33186, while L. reuteri RC-14 displayed higher 
longitudinal relaxivity than S. aureus Newman, P. mirabilis 296 and P. aeruginosa PA01 (Table 
8, p < 0.05). These data suggest that R1 measurements may be useful for differentiating some 
lactobacilli from other bacterial species (Table 8). Raw MR data for all bacterial species 
examined are found in Appendix 12. 
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Figure 16. MR measurements of different bacterial species vary widely. Cultures from 
different bacterial species were mounted in a gelatin cell phantom for MRI at 3T. In all cases, the 
R2* 
R2 
A 
B 
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R2 component of transverse relaxivity (blue bars, B) dominates the total R2* signal (red bars, 
A). Lactobacillus gasseri ATCC33323 displayed significantly higher R2 and R2* than any other 
species tested (A and B; *** p < 0.001). Lactobacillus rhamnosus GR-1 displayed higher 
relaxivity than L. reuteri RC14, as well as higher R2 than S. aureus USA300 and S. epidermidis 
ATCC35984 (A and B; light gray lines; p < 0.05). P. mirabilis 296 and S. aureus Newman  
displayed lower transverse relaxivity than several other species imaged (A and B; black and gray 
lines respectively). Bar graphs show mean +/- SEM (n = 3 – 5). 
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Table 8. Longitudinal relaxation rates for various bacterial species 
Sample ^ R1 (s-1) SEM (s-1) n-value 
P. aeruginosa PA01 1.04 d 0.14 4 
S. epidermidis ATCC35984 1.49 cd 0.07 4 
K. pneumoniae 280 1.25 cd 0.01 3 
E. faecalis ATCC33186 2.04 bcd 0.10 3 
P. mirabilis 296 0.92 d 0.05 3 
S. aureus USA300 1.37 cd 0.10 3 
S. aureus Newman 1.17 d 0.15 4 
L. gasseri ATCC33323 3.34 ab 0.32 5 
L. rhamnosus GR-1 3.77 a 0.66 4 
L. reuteri RC-14 2.60 abc 0.05 3 
^ Mean R1 values followed by the same letter are not significantly different (α = 0.05) based on 
Tukey’s test. 
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3.3.2 Fe and Mn quantification in various bacterial species 
Cell lysates of bacterial strains were examined using ICP-MS to quantify total cellular iron and 
manganese content and correlate these measures to MR relaxivity. Iron was below detectable 
levels in all samples of Lactobacillus spp. examined (Figure 17A). Both S. aureus Newman and 
K. pneumoniae 280 samples contained significantly more iron than lactobacilli (Figure 17A; p < 
0.001 and p < 0.05 respectively). Manganese levels varied widely between bacteria, ranging from 
0.014 – 111.9 µg Mn / mg protein (Figure 17B). Staphylococcus aureus Newman contained more 
Mn than P. mirabilis 296, while all other significant differences were due to the high Mn of 
lactobacilli. Lactobacillus rhamnosus GR-1 and L. crispatus ATCC33820 had higher manganese 
than all non-Lactobacillus species except S. epidermidis. Lactobacillus reuteri RC-14 had 
significantly more Mn than P. aeruginosa, K. pneumoniae or P. mirabilis, while L. gasseri 
ATCC33323 only had significantly more Mn than P. mirabilis 296 (Figure 17B; p < 0.05). Raw 
ICP-MS data are available in Appendix 13. 
These data show that both Fe and Mn levels vary widely between different bacterial species, and 
Mn especially may contribute extensively to the high MR relaxation rates of Lactobacillus spp. 
However, the high R2 and R2* of L. gasseri ATCC33323 cannot be fully attributed to Mn levels, 
which are relatively low for this strain. 
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Figure 17. Elemental iron and manganese content vary widely between bacterial species. 
Iron and manganese were quantified by ICP-MS and normalized to total protein. Both iron (A, 
blue) and manganese (B, red) content varied between bacterial species. All lactobacilli examined 
contain extremely high levels of Mn, but undetectable Fe (N.D., not detectable). Data are 
B 
A 
Iron Concentration 
(µg Fe / mg protein) 
Manganese Concentration 
(µg Mn / mg protein) 
* 
* 
* 
* 
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displayed as individual values with mean +/- SEM (n = 3). In panel A, iron content of S. aureus 
Newman and K. pneumoniae were significantly higher than that of all lactobacilli examined 
(black lines, * p < 0.05, *** p < 0.001). In panel B, the Kruskall-Wallis test with Dunn’s multiple 
comparisons showed that P. mirabilis contained less Mn than E. faecalis, S. aureus Newman, and 
L. gasseri (black lines) and L. reuteri, L. rhamnosus and L. crispatus samples each contained 
more manganese than most other bacterial species examined (dark gray, light gray and light blue 
lines respectively). 
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3.3.3 Measuring MR relaxivity of L. crispatus ATCC33820 
As mentioned in section 3.3.1, the signal intensity of L. crispatus ATCC33820 decayed to 
baseline before the first TE, preventing the measurement of MR relaxation rates in a compact 
pellet. To overcome the rapid signal decay, L. crispatus was serially diluted in 4 % gelatin / PBS 
so that signal intensity could be measured before it decayed completely. Following a ½ dilution, 
signal intensity still decayed to background levels by the third TE (25 ms) but R2 and R2* were 
nevertheless measurable. Indeed, since transverse relaxation rates were more reliable as the 
dilution factor increased, this suggests that L. crispatus may be detected by MRI even when 
relatively few cells are present (Figures 18 and 19). 
Longitudinal relaxivity does not vary significantly in samples containing 25-50% L. crispatus 
ATCC33820, however R1 in samples diluted 1/8 was significantly lower than those diluted 1/4 
(Table 9, p < 0.01). When L. crispatus represented less than 10% of the total sample (1/16 
dilution), R1 was significantly lower than all other dilutions examined (Table 9, p < 0.001). 
Individual transverse and longitudinal relaxation rate measurements are found in Appendix 14. 
Since the number of CFUs within the MR slice varies with each replicate, we explored the 
correlation between number of CFUs in the MR slice (where the signal is acquired) and its 
relaxation rate. Both R2 and R2* show moderate positive linear correlations to the number of 
live cells (Figure 19A and B; p < 0.001). Thus, as the number of live cells in the ROI increases, 
so do the MR measurements.  
On the other hand, R2 and R2* of L. crispatus ATCC33820 were strongly correlated to the 
percentage of cells in the sample (Figure 20). Based on these strong positive correlations and 
using the linear regression equations, we estimate that R2 for undiluted L. crispatus (where f = 
100 %) is ~ 308 s-1 and R2* is ~ 339 s-1. These estimated values are at least 3 -fold higher than 
any other species examined, explaining the initial difficulties in measuring MR parameters for L. 
crispatus ATCC33820. 
Based on the moderate, positive linear correlation between CFUs in the slice and fraction of 
cells, we can estimate the average number of CFUs required to fill the Ultem well at any dilution 
factor (Figure 21). For example, if we were not diluting, but using 100% L. crispatus, the MR 
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slice would be comprised of ~9.51 x 109 CFUs, with ~2.85 x 1010 CFUs needed to fill the entire 
well. Overall, these L. crispatus dilution experiments demonstrate that a commensal bacterium of 
the urogenital tract may be a good target for in vivo imaging of bacteria using MRI. 
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Figure 18. Transverse relaxivity of serially diluted L. crispatus ATCC33820. Lactobacillus crispatus 
displays high transverse relaxation rates after dilution in gelatin / PBS. Bar graphs show the mean +/- 
SEM (n = 5, except at 1/32 n = 2). Samples diluted 1/2 contain approximately 2.02 x 1010 CFUs within 
the MR slice; the 1/4 dilution contains ~1.01 x 1010 CFUs / slice; the 1/8 dilution contains ~5.05 x 109 
CFUs / slice; the 1/16 dilution contains ~ 2.53 x 109 CFUs / slice; and 1/32 diluted samples contain ~ 7.83 
x 107 CFUs / slice. 
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Table 9. Longitudinal relaxation rates for serially diluted L. crispatus ATCC33820 
Sample a Average CFUs / MR slice ^ R1 (s-1) SEM (s-1) n-value 
1/2 L. crispatus 2.02 x 1010 3.74 ab 0.25 4 
1/4 L. crispatus 1.01 x 1010 4.06 a 0.14 5 
1/8 L. crispatus 5.05 x 109 3.22 b 0.11 5 
1/16 L. crispatus 2.53 x 109 1.94 c 0.06 5 
a All samples were serially diluted in 4% gelatin / PBS 
^ Mean R1 values followed by the same letter are not significantly different (α = 0.05) based on 
Tukey’s test. 
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Figure 19. MR measures of L. crispatus ATCC33820 are moderately correlated to number of 
live cells. Plots of R2 (A) and R2* (B) show individual MR measures and cell number expressed 
as CFUs within each MR slice. For both R2 and R2*, Pearson’s line of best fit provides a 
moderately positive linear correlation between number of CFUs and transverse relaxation rate (p 
< 0.001).  
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Figure 20. MR measures vs. fraction of cells (f) for serially diluted L. crispatus ATCC33820. 
Fraction of L. crispatus cells (f), shown as a percentage, is strongly correlated to R2 (A) and R2* 
(B) measurements (p < 0.001). 
  
r2 = 0.9406 
y = 2.988x + 9.556 
r2 = 0.9217 
y = 3.228x + 16.04 
B 
A 
100 
 
0 10 20 30 40 50
0
2×109
4×109
6×109
8×109
f
CFUs
  
Figure 21 Percent of L. crispatus ATCC33820 cells (f) are moderately correlated to number 
of live cells. Circles show colony forming unit counts (CFUs) within the MR slice (21 voxels in 
a 3 mm slice through the well ≈ 38 mm3) of individual samples as a function of the percentage of 
cells (f) loaded into the wells after serial dilution in gelatin/PBS. The line represents a moderate, 
positive linear correlation between CFUs and f (p < 0.01). The scatter plot shows the range in 
number of live cells that may contribute to the MR signal in any given well of the cell phantom, 
irrespective of dilution factor. The line of best fit shows the average number of live cells required 
to fill the MR slice at any given dilution factor. 
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3.3.4 MRI signal from mixtures of human bladder cells and L. 
crispatus 
To explore the potential for distinguishing MR relaxivity in two distinct cell types within a single 
sample, we examined mixtures of human 5637 bladder cells and L. crispatus ATCC33820 at 
varying ratios. From the decay curves, it is apparent that transverse relaxivity in these mixed 
samples is mono-exponential and not bi-exponential (Figure 22). These data show that, using our 
MR sequences and analysis techniques, we were unable to resolve the bacterial and mammalian 
MR signals (Figure 22).  
In addition, the mono-exponential decay of these mammalian and bacterial cell mixtures shows 
that R2* values are similar to those of L. crispatus alone, diluted in gelatin. However, R2 values 
are markedly lower than those measured in purely bacterial phantoms (compare Figures 18 and 
23). Thus, while L. crispatus diluted in gelatin has little to no R2' component, when diluted in the 
presence of bladder cells, the R2* signal consists of approximately half R2 (the irreversible 
component of transverse relaxivity) and half R2' (the reversible component of transverse 
relaxivity).  
R2*, R2 and R2' of human 5637 bladder cells alone are also quite substantial (R2* = 22.01 s-1). 
For comparison, human melanoma MDA-MB-435 cells have R2* of 13.70 s-1 32 and mouse 
embryonic adenocarcinoma P19 cells have R2* of 13.5 s-1 34. These are nevertheless much lower 
than transverse relaxation rates of the lactobacilli, with R2* of 180 s-1 when diluted 1/2 in 
gelatin. Raw transverse relaxation rate measurements are shown in Appendix 15. 
R2, R2* and R2' are strongly linearly correlated to the fraction of L. crispatus ATCC33820 cells 
in mixed samples (Figure 24). When comparing the linear regression slope of transverse 
relaxivity with fraction of L. crispatus either diluted in gelatin or in 5637 bladder cells, R2, but 
not R2*, signal attenuation by bladder cells is demonstrated by the moderate slope of the mixed 
sample compared to the steep slope of the gelatin-diluted L. crispatus (Figure 25). R2/R2* ratios 
of L. crispatus diluted in bladder cells are significantly lower than those diluted in gelatin (Table 
11; p < 0.001). Longitudinal relaxation rates of mixed bladder cell and L. crispatus samples 
(Table 10) are also attenuated in comparison to L. crispatus diluted in gelatin (Table 9). 
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Figure 22. Signal intensity decays mono-exponentially with echo time (TE) in mixed 
samples of 5637 bladder cells and L. crispatus ATCC33820. The decay of T2 (A) and T2* (B) 
fits a mono-exponential curve, providing little or no distinction between mammalian and 
bacterial MR contributions. Open and closed circles (lines 1 and 6) show the signal decaying in 
bladder cells alone; open and closed squares (lines 2 and 7) show the signal decaying in bladder 
cells mixed with 1/16 L. crispatus; open and closed triangles (lines 3 and 8) show the signal 
decaying in bladder cells mixed with 1/8 L. crispatus; inverted triangles (line 9) show the signal 
decaying in bladder cells mixed with 1/4 L. crispatus;open and closed diamonds (lines 5 and 10) 
show the signal decaying with equal amounts of mammalian and bacterial cells (i.e. 1/2 L. 
crispatus).   
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Figure 23. Transverse relaxation rates in serial dilutions of 5637 bladder cells and L. 
crispatus ATCC33820. Cultured cells were resuspended in PBS before serially diluting L. 
crispatus cells in human bladder cells. Cell mixtures were packed into Ultem wells by 
centrifugation and mounted in a cell phantom for MRI at 3T. Bar graphs show the influence of 
increasing proportions of  L. crispatus on bladder cell transverse relaxation rates. Irrespective of 
dilution, R2 (blue bar) measurements are approximately half of the R2* signal (red bar) 
compared to L. crispatus alone (Figure 17). In this respect, L. crispatus appear to contribute 
more to the total transverse relaxation rate (R2*) than to the irreversible component (R2). Bar 
graphs show the mean transverse relaxivity; individual relaxation rate values are indicated with 
black circles (n = 1 – 2). For a 1/2 dilution, the mean L. crispatus CFUs in the MR slice is 3.46 x 
108; for 1/4, it is 1.99 x 108 CFUs / slice; for 1/8, it is 1.07 x 107 CFUs / slice; for 1/16, it is 6.39 
x 107 CFUs / slice. Median number of bladder cells in the slice for a 1/2 diluted sample is 6.03 x 
106 cells / slice; the 3/4 sample contains 7.54 x 106 bladder cells; the 7/8 sample contains 8.48 x 
106 bladder cells; the 15/16 sample contains 1.05 x 107 bladder cells; and the 100% bladder cell 
sample contains 2.14 x 107 cells. 
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Table 10. Longitudinal relaxation rates of mixed samples of 5637 bladder cell and L. crispatus 
ATCC33820 
Sample  a L. crispatus 
CFUs / slice 
a 5637 cells / 
slice 
R1 values (s-1) 
Sample 1 Sample 2 
1/2 L. crispatus, 1/2 5637 cells 346 x 106 6.03 x 106 2.43 2.41 
1/4 L. crispatus, 3/4 5637 cells 199 x 106 7.54 x 106 2.41 2.41 
1/8 L. crispatus, 7/8 5637 cells 107 x 106 8.48 x 106 1.79 1.87 
1/16 L. crispatus, 15/16 5637 cells 63.9 x 106 10.5 x 106 1.77 1.38 
5637 cells alone 0 21.4 x 106 0.69 0.70 
a Counts are displayed as the median of 2 replicates. 
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Figure 24. Transverse relaxivity vs. fraction of bacterial cells (f) for L. crispatus 
ATCC33820 serially diluted in 5637 bladder cells. Fraction of L. crispatus cells is strongly 
positively correlated to R2 (A), R2* (B) and R2' (C) measurements. 
  
r2 = 0.9163 
y = 1.131x + 19.75 r2 = 0.9278 
y = 2.645x + 38.87 
A  B 
r2 = 0.8377 
y = 1.515x + 19.12 
C 
106 
 
0 10 20 30 40 50
0
50
100
150
200
f
Transverse
relaxation
rate (1/s)
R2* crispatus / 5637
R2 crispatus / 5637
R2* crispatus / gelatin
R2 crispatus / gelatin
 
Figure 25. R2* and R2 vs. fraction of bacterial cells (f) for L. crispatus ATCC33820 serially 
diluted in 5637 bladder cells or gelatin. Fraction of L. crispatus is strongly correlated to MR 
measures: R2* (squares) and R2 (circles). Red symbols denote mixed samples of L. crispatus 
and 5637 cells; blue symbols denote L. crispatus diluted in gelatin. Lines demonstrate the linear 
regression within each sample type and MR measure. Individual Pearson correlation coefficients 
can be found in Figures 18 A and B as well as Figure 23 A and B, though all r2  > 0.91. Fraction 
of live L. crispatus cells is strongly positively correlated to transverse relaxivity whether diluted 
in gelatin or bladder cells. In the presence of bladder cells, R2, but not R2* relaxivity is 
attenuated, giving rise to a prominent R2' component. 
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Table 11. R2/R2* ratios for L. crispatus ATCC33820 dilutions 
L. crispatus a 50% 25% 12.5% 6.25% 3.125% 
d Mean 
R2 / R2* 
SD p-value 
Gelatin b 
1.06 0.92 1.05 0.60 0.78 
0.84 0.13 
< 0.001 
0.78 0.96 0.98 0.73 0.77 
0.87 1.01 0.96 0.61   - 
0.94 0.64 0.80 0.85   - 
0.87 0.82 0.75 0.75   - 
5637 cells c 
0.45 0.54 0.53 0.48 0.89 
0.50 0.17 
0.42   - 0.52 0.29 0.36 
a L. crispatus samples are displayed as the percent bacterial cells within the sample. 
b L. crispatus cells were serially diluted in gelatin/PBS (n = 22) 
c L. crispatus cells were serially diluted in 5637 bladder cells (n = 9) 
d R2/R2* ratios between L. crispatus/gelatin and L. crispatus/5637 cells were compared using 
the unpaired Mann-Whitney test. 
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3.3.5 Effect of iron acquisition mutations on MR relaxation rates 
and cellular iron and manganese content 
To explore how iron storage in the form of ferritin contributes to MR relaxation rates of bacteria, 
we examined S. aureus USA300 and two related iron acquisition mutants. We assessed wildtype 
(WT) USA300 as well as a mutant deficient in the siderophores staphyloferrin A and 
staphyloferrin B (Δsfa/Δsbn). In addition, we examined a ferritin A deletion mutant bearing the 
siderophore deficient background (Δsfa/Δsbn/ΔftnA). All 3 bacterial strains were grown in iron-
replete and iron depleted media. 
Both S. aureus iron mutants displayed similar MR relaxation rates as the wild type when grown 
in iron-rich broth (Figure 26A). Under conditions of iron starvation, the transverse relaxivity did 
not change (Figure 26A and B). Longitudinal relaxivity was likewise unchanged in both iron 
replete and iron depleted media (Table 12). Neither siderophore deficiency nor lack of ferritin A 
storage protein altered the MR relaxation rates (Figure 26B, Table 12), suggesting that other 
forms of iron uptake and storage may be compensating for these mutations. Iron content may 
vary between these S. aureus mutants (Figure 27A), with little or no change in total cellular 
manganese content under iron depleted conditions (Figure 27B). Raw MR and ICP-MS data are 
available in Appendices 16 and 17 respectively. 
Overall these data indicate that defects in ferritin iron storage and transient redox active iron do 
not affect MR relaxation rates in S. aureus.  
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Figure 26.  Transverse relaxation rates for S. aureus USA300 iron mutants grown under 
iron-replete and iron depleted conditions. Wildtype (WT), siderophore deficient (Δsfa/Δsbn) 
and siderophore deficient, ferritin A deletion (Δsfa/Δsbn/ΔftnA) mutants were grown in either 
iron-replete (A) or iron depleted (B) medium and examined by MRI. Mutations in these select 
iron acquisition genes do not alter transverse relaxation rates in S. aureus USA300 (n = 3, except 
for mutants in the iron-replete condition where n = 2). 
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R2 
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Table 12. Longitudinal relaxation rates for S. aureus USA300 and iron acquisition mutants 
Strain R1 (s-1) SEM (s-1) n-value 
WT a 1.37 0.10 3 
WT b 1.22 0.06 3 
Δsfa/Δsbn b 1.20 0.06 3 
Δsfa/Δsbn/ΔftnA b 1.32 0.09 3 
a Bacteria were cultured in iron-replete medium. 
b Bacteria were cultured in iron depleted medium. 
WT, wildtype  
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Figure 27. Iron and manganese content in S. aureus USA300 iron acquisition mutants 
grown in iron depleted conditions. Staphyloferrin A and B deficiency (Δsfa/Δsbn) and ferritin 
deletion, siderophore deficient (Δsfa/Δsbn/ΔftnA) mutants grown in iron-starved conditions may 
have lower total cellular iron content but similar manganese content than wildtype (WT) bacteria 
when grown in iron-rich conditions (n = 2 – 3). 
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3.4 Discussion 
Using a gelatin cell phantom, we explored the MR relaxation rates of various commensal, 
probiotic and pathogenic bacteria encountered in the urogenital tract. We found high variability 
in transverse relaxivity, with MR signatures of Lactobacillus spp. dominating. Overall, there was 
little variability in iron content, but large variability in manganese content between bacterial 
species. The commensal and probiotic lactobacilli were characterized by extremely high 
manganese content which may be contributing to high transverse relaxivity since iron content in 
these species was below the ICP-MS detection limit.  
Regardless of the high variability in transverse relaxivities among different species of bacteria, 
many of these measures are much higher than previously recorded in mammalian cells32, 34. 
Interestingly, all bacteria examined display little to no R2' component (R2* - R2). We suggest 
that exploring differences in the form of metals (protein-bound, sequestered metals compared to 
free redox active forms) within a cell may be informative and help us fully understand the 
breakdown of transverse relaxivity components. As discussed in section 2.4, the SE and GRE 
sequences we used may contain systematic errors that led to R2* < R2. In future work further 
refinement of the pulse sequence parameters as well as comparison with other MR sequences 
should be consider prior to making measurements aimed to define differences in R2 and R2* 
relaxivity of bacteria. 
High transverse relaxation rates of L. crispatus ATCC33820 may allow easier detection of this 
bacterium even at lower MRI field strength, since R2 and R2* are generally proportional to field 
strength35. Furthermore, given the moderate positive correlation between MR parameters and 
number of CFUs, in vivo imaging of L. crispatus ATCC33820 and estimation of the number of 
live cells within an ROI should be feasible. For example, fewer than 108 CFUs of L. crispatus 
within an ~38 mm3 ROI provides a measurable MR signal (greater than most mammalian tissues 
but low enough to enable relaxivity measurements), with estimated R2 values above 25 s-1 and 
within the detectable range of current 3T clinical scanners. Using our current MR sequences it 
would be near impossible to directly measure transverse relaxivity of undiluted L. crispatus as its 
signal intensity decays within milliseconds, with estimated R2 exceeding 300 s-1. This would be 
a problem rarely encountered in healthy individuals in vivo where bacteria are more 
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homogeneously distributed within their nichesIn the future, technological advancements in MRI 
should enable even better resolution for detection of fewer bacteria and newer sequences like 
ultrashort echo time (UTE) sequences may be useful in visualizing the fast signal decay for 
bacteria with large R236.  
Iron levels vary widely between bacteria, but undetectably low iron was seen in all lactobacilli. 
Likely, this is because Lactobacillus spp. don’t generally use iron as a cofactor27, 31, 37. This 
provides a growth advantage to them in the low iron environments of the urogenital tract. 
However, during menses when iron levels are increased, some lactobacilli such as Lactobacillus 
iners continue to thrive, whereas L. crispatus levels generally decrease and recover only as iron 
levels decrease 38, 39. Previous research suggests that low molecular weight species of manganese 
play a role in blocking the production of reactive oxygen species and prevent lipid peroxidation, 
allowing lactobacilli to safely accumulate high levels of intracellular Mn31, 40. Large amounts of 
iron, on the other hand, lead to increased production of free radicals which can lead to DNA 
damage and lipid peroxidation which are harmful to cells41. Thus, it is not surprising that there is 
high manganese uptake in all our examined lactobacilli, as their growth medium, MRS, contains 
approximately 330 µM Mn31 whereas manganese levels in LB are approximately 1000-fold less 
(closer to 200 nM42). While manganese is a required cofactor in many bacteria, including 
lactobacilli30, 37, high Mn in our samples may be bound externally to the cell membrane or 
peptidoglycan as well as internalized. Lactobacilli are known to bind some heavy metals like 
cadmium, lead and mercury16. The possibility that manganese is also externally bound cannot be 
discerned from our study though this has not been previously observed in these bacteria. A 
preliminary genome search of L. crispatus ATCC33820 indicates the presence of non-specific 
metal transporters which may have the ability to import Mn (data not shown). There is also a 
manganese transporter, MtsA, conserved across Streptococcus spp. among others, including 
some Lactobacillus strains30, 43. 
Although we hypothesize that high Mn content in lactobacilli is promoting high MR relaxivity, 
there  is a discrepancy between elemental Mn levels and transverse relaxation rates in the species 
tested. For example, L. gasseri ATCC33323 has an R2 value of approximately 75 s-1 while L. 
rhamnosus GR-1 has a lower R2 of ~48 s-1, although these MR signatures are not significantly 
different, total cellular Mn content varies significantly with that of GR-1 approximately 50-fold 
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higher than that of L. gasseri (~53 µg Mn / mg protein versus ~1 µg Mn / mg protein, 
respectively). Since higher manganese does not necessarily equate to higher transverse 
relaxivity, and we see that iron content is negligible, other factors appear to be at play. These 
factors may include, but are not limited to, bacterial size and morphology relating to the density 
of packed cells within an ROI, water content of samples, as well as the presence of other MR 
sensitive elements that we did not assess, including nickel, cobalt and gadolinium. Although 
gadolinium is not typically found in bacteria, genomes of certain species including Salmonella 
enterica, Campylobacter jejuni and Bacillus subtilis are known to encode nickel and/or cobalt 
transport genes44. 
In vivo, MRI voxels will generally contain both bacterial and mammalian cells since few bacteria 
are free floating within the human microbiota and bacteria can adhere to mammalian tissues via 
pili as well as biofilm formation on mammalian structures and abiotic materials such as catheters 
or stents45. Although microbial diversity varies between each microenvironment46, all clinical 
microbiota samples are mixed, as various species live symbiotically. Therefore, it is important to 
assess how MR relaxivity changes in response to mixed bacterial samples and 
bacterial/mammalian mixtures compared to single strain cultures. In this study, we assessed 
mixed samples of L. crispatus ATCC33820 and human 5637 bladder cells using an MRI cell 
phantom, however, using single echo SE and GRE MR sequences, we were unable to distinguish 
the bacterial signal decay from mammalian signal decay: all curves were monoexponential. 
Within our mixed samples we found that total transverse relaxivity was extremely high, with 
R2* values of bacterial/mammalian cell mixtures similar to the R2* of L. crispatus/gelatin (170 
s-1 vs. 180 s-1 respectively in 1/2 dilutions). However, R2 was greatly attenuated by the addition 
of bladder cells compared to the gelatin/PBS background (73.2 s-1 vs. 161 s-1 respectively) which 
is easily visualized by the change in slope of the line of best fit demonstrating the relationship 
between transverse relaxivity and fraction of L. crispatus cells. Comparison of R2/R2* ratio in L. 
crispatus/gelatin versus L. crispatus/bladder samples (0.89 and 0.43 respectively for 1/2 L. 
crispatus dilutions) can also demonstrate the R2 attenuation by bladder cells. Although the R2* 
signal remained similar, the R2 signal attenuation led to a significant increase in R2′ potentially 
related to differences in water diffusion in gelatin compared to bladder cells. Further examination 
of the effects of mixed cultures is warranted as well as viability assessments for the bladder cells 
to determine whether the cells are intact and viable.  
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Finally, we used S. aureus USA300 and related siderophore and ferritin mutants to model how 
iron storage contributes to MR relaxivity in bacteria. However, in this species we detected no 
changes in MR measures despite changes in the availability of extracellular iron and key iron 
handling proteins. Due to low sample size, we are unable to confirm changes in iron content, 
though the invariant MR measures suggest the potential decrease in iron content may be 
insignificant for MR purposes. There are redundancies in iron import and storage pathways that 
work to maintain iron homeostasis in S. aureus including the isd, feo, sir, sst, and fhu systems47, 
though staphyloferrin A and B are the major siderophores present in this species26, 48, 49. This 
redundancy promotes survival by ensuring that bacteria get the iron required for growth in iron-
replete or iron-deplete conditions. Ferritin A is the main iron storage protein of Staphylococci but 
the Dps homologue mrgA also encodes another iron storage protein, though MrgA in S. aureus is 
suspected of playing a larger role in DNA binding as opposed to iron storage50, 51. Nonetheless, 
this alternative iron storage protein may compensate for the iron storage needs of an 
Δsfa/Δsbn/ΔftnA mutant. Redundancies in iron handling genes as well as the lethality of iron 
starvation provide a barrier to understanding how iron storage contributes to transverse relaxivity 
in bacteria. 
 
3.5 Conclusions 
We assessed 12 distinct bacterial isolates and found that MR relaxation rates in all species may 
be influenced by total cellular iron and manganese contents, among other factors. Each 
bacterium has a unique and replicable MR signature which we suggest is a property of the 
bacteria due to their intrinsic metal handling capabilities. Using bacteria with extremely high 
transverse relaxivity at various dilution factors, we were able to relate MR measures to the 
quantity of live bacterial cells in vitro. Though we were unable to separate distinct transverse 
relaxivities of bacterial and mammalian cells within a mixed sample, bacterial R2 relaxivity was 
attenuated by the addition of bladder cells. Due to redundancies in both iron acquisition and 
storage in S. aureus, it is difficult to assess how the form of iron can influence MR relaxivity. 
Our findings suggest that detection of bacteria using MRI is feasible, especially for imaging 
lactobacilli with high MR relaxivity. Future applications involving in vivo bacterial cell detection 
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and potentially tracking within the human host will depend on the possible additive or 
attenuating effects of mixed cultures and the potential for differentiating individual MR 
signatures within these complex cultures.  
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Chapter 4: Summary 
 
4.1 Summary 
In this study we examined the MR relaxation rates of bacteria that may be encountered in the 
human urogenital or gut microbiome. Most, if not all bacteria we imaged displayed high 
transverse relaxivity, much higher than that of mammalian cell lines examined using the same 
MR sequences1-3. This transverse relaxivity was dominated by R2, with little to no R2' 
contribution. These findings may be associated with the form of metals within the cell. It has 
been previously found that 99% of all intracellular iron in E. coli is stored in protein aggregates 
to limit DNA  and cellular damage4, 5. 
There was little to no variation in longitudinal relaxivity between bacterial strains or species, 
likely due to low basal R1 values. Though the MR measures did not distinguish between 
commensal or pathogenic bacterial groups, bacterial strains exhibited differences in transverse 
relaxivity.  
We found that MR measures for L. crispatus are proportional to the number of live cells within 
the imaged sample (Figure 19). In addition, MR measures varied between strains of E. coli and 
between various species of bacteria in part due to differential metal handling, with MR 
relaxivities of Lactobacillus spp. dominating. Overall, there was little variability in iron content, 
but large variability in manganese content between bacterial species. The commensal and 
probiotic lactobacilli were characterized by extremely high manganese content which may 
explain the high transverse relaxivity despite undetectable levels of iron. Potentially, bacterial 
size and morphology as well as the presence of other MR sensitive elements may contribute to 
MR relaxivity. 
Since iron content is positively correlated to transverse relaxation rates in iron-supplemented 
MagA-expressing mammalian cells1, 2, 6, we assessed the impact of MagA expression in E. coli 
on MR relaxivity. MagA-expressing cells displayed iron-associated cytotoxicity.  Since iron is 
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tightly regulated in E. coli to prevent toxicity4, future MagA expression studies may need to 
introduce tighter regulatory systems involving repressors of transcription. While MagA 
expression offered no advantage in our laboratory model, the inherently high R2 of 
untransformed E. coli strains among other bacteria suggests that contrast enhancement may be 
unnecessary for visualizing bacteria by MRI when they are present in sufficient quantities. For L. 
crispatus ATCC33820, potentially as few as ~26 x 106 CFUs per mm3 may be visible by MRI at 
clinical field strength. The linear correlation between MR transverse relaxation rates and number 
of L. crispatus ATCC33820 CFUs demonstrates the potential to estimate number of live bacteria 
within a region of interest for future in vivo imaging applications. 
High bacterial transverse relaxivity may be useful in differentiating the MR signal of bacteria 
from human tissue and provides a potentially important foundation for future studies using in 
vivo MRI to detect bacteria and observe their interactions. In vivo, pure single-strain bacterial 
niches are not expected, and MR regions of interest may contain both bacterial and mammalian 
cells. Therefore, we assessed how MR relaxivity changes in response to bacterial/mammalian 
mixtures compared to single strain cultures. Using our MR sequences, we were unable to 
distinguish bacterial signal decay from the mammalian bladder cell signal based on the 
monoexponential fit of the decay curve. Nonetheless, R2 was greatly attenuated by the addition 
of bladder cells compared to a pure bacterial sample, leading to a significant increase in R2′ 
when bacteria were mixed with mammalian cells as well as lower R2/R2* ratios. This change in 
R2* composition may allow us to identify prokaryotic/eukaryotic interfaces in vivo from luminal 
regions of interest containing predominantly bacteria. 
Finally, MR relaxivity was unchanged by iron availability in S. aureus USA300 and related 
siderophore and ferritin mutants, while potential changes in iron content must be assessed 
further. Though staphyloferrin A and B are the key siderophores present in S. aureus7-9 with 
ferritin as the main iron storage protein, there are alternative pathways for these bacteria to 
import and store iron. Redundancies in iron handling genes as well as the lethality of iron 
starvation provide a barrier to understanding how iron storage contributes to transverse relaxivity 
in bacteria. 
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4.2 Future Directions 
Although bacteria exhibit high transverse relaxivity, it would still be useful to explore alternative 
forms of MR contrast enhancement aside from MagA to improve detection, enable reporter gene 
expression of molecular activity, and increase the sensitivity of our imaging technique. Multi-
modality imaging will likely be important for accurate bacterial detection and tracking in vivo. 
This could be achieved by externally labeling bacteria of interest with radioisotopes for 
simultaneous positron emission tomography (PET)/MR imaging (Biomedical Imaging of 
Bacteria and Viruses worldwide patent L-21-002). Ultrasound probes, such as those developed in 
previous bacterial studies10, also provide promising candidates for multi-modality imaging 
applications. Nonetheless, the high spatial resolution and high sensitivity provided by current 
MRI systems make it an ideal modality to pursue. With future technological advancements we 
expect to see more powerful MRI systems with higher sensitivity, better resolution, as well as 
new pulse sequences that improve signal-to-noise ratios and signal acquisition times. Although 
cost is currently a major barrier in the widespread implementation of MRI (among other 
modalities), as imaging becomes the standard of care costs will likely decrease and allow for 
greater accessibility and promote even more interdisciplinary applications of imaging. The utility 
of the sequences we employed to assess bacterial MR relaxation rates must also be assessed in 
future studies. As mentioned in sections 2.4 and 3.4, flip angle errors in these sequences or 
inconsistent application of echo-spacing may have led to inaccuracies in R2 and R2* 
measurements that make it difficult to compare these values directly.  In some cases, we found 
R2 values appeared greater than R2*, which we know cannot be the case.  We propose 
comparing the R2* values obtained from the multi-echo GRE sequence used to a single-echo 
GRE sequence in a future cell phantom experiment to demonstrate the measurement variation. In 
future studies we may also explore ultrashort echo time (UTE) sequences to improve transverse 
relaxivity measurements for bacteria. 
To further corroborate our findings of intrastrain MR variability, we would like to examine other 
L. crispatus strains, especially strains like L. crispatus 20 which lacks the MtsA metal transport 
gene. Could MtsA protein be responsible for large quantities of Mn uptake, thus promoting 
unique MR signatures of lactobacilli? Since high manganese content may be associated with  
high MR signal for many lactobacilli, it would also be interesting to culture these bacteria in 
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varying manganese titers, including saturation of Mn uptake to assess whether further manganese 
loading might improve the detection limit of lactobacilli by MRI. This could be achieved by 
growing the lactobacilli in a Mn deplete medium and adding Mn back as previous studies have 
shown: intracellular Mn should be proportional to Mn supplementation up to 150 µM11. We note 
that the deMan, Rogosa and Sharpe (MRS) medium we used in the present study contains more 
than double that concentration of manganese, with 330 µM Mn 12. Perhaps Mn supplementation 
could be used to selectively enhance the MR relaxivity of lactobacilli, permitting specific 
detection of these commensal bacteria through their Mn uptake abilities which far supersede that 
of other bacterial species examined in this thesis. 
Further evaluation of mixed prokaryotic/eukaryotic samples is necessary. It would be interesting 
to assess whether transverse relaxivity in mixtures of 5637 bladder cells and L. crispatus 
ATCC33820 could be accurately measured using larger fractions of bacterial cells (60-90%). 
Even if R2* measurements were not possible due to rapid signal decay, a measurable decrease in 
R2 might still be obtained in the presence of fewer mammalian cells (10-40%). This would be 
important for understanding MRI in microbiotas of lower bacterial diversity, for example those 
with largely lactobacilli like the vagina or the bladder13, 14. How MR relaxation rates change in 
response to diseases like bacterial vaginosis or UTI is currently unknown. It is crucial to assess 
complex bacterial cultures in vitro, potentially those from fecal or chemostat samples, to 
understand the implications of in vivo bacterial detection and the limitations that may be 
encountered. 
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Appendix 1. Impact of bacterial growth media on MR measures. The bar graph compares 
longitudinal (R1) and transverse (R2*, R2) relaxation rates +/- SEM of various growth media 
mounted in a gelatin phantom and scanned at 3T. Bacteria were excluded from each broth: LB, 
lysogeny broth; AU, artificial urine; BHI, brain-heart infusion; and MRS, deMan, Rogosa, 
Sharpe. While the signals from LB and AU are comparable to gelatin/PBS, BHI and MRS 
significantly increased relaxation rates (n = 3 – 4, except n = 2 for AU; * p < 0.05, *** p < 
0.001). 
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Appendix 2. Total cellular iron and manganese do not reliably predict transverse 
relaxivity. Elemental iron and manganese content of various E. coli strains was measured by 
ICP-MS and related to matched MR relaxation rates. Based on Spearman’s test, iron (A) and 
manganese (B) do not correlate to R2 measurements. Iron (C) has a weak positive correlation to 
R2* measurements (r2 = 0.141 respectively, p < 0.05) while manganese (D) does not correlate to 
R2* measurements. No correlations exist within individual classification groups. 
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Appendix 3. Amplified HA-magA-myc. The insert HA-magA-myc DNA was amplified from 
pcDNA3.1MycHisA+/HA-magA by PCR using a 56 °C annealing temperature and 30 cycles. 
Primers are listed in Table 3. Lane 1 contains a 1 Kb DNA ladder. Lane 2 contains a Taq 
polymerase negative control with no HA-magA-myc amplification. Lanes 3 and 4 contain 
amplified HA-magA-myc (1467 bp) using either 1 or 10 ng/µL template, respectively. The 
conditions in lane 4 were chosen for all subsequent PCR amplifications. 
  
1      2     3      4 
1.6 kB 
1 kB 
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Appendix 4. Qualitative differential protein expression following induction of MagA 
expression in E. coli BL21(DE3). Total protein was isolated from bacterial cells untransformed 
(lanes 1–2), transformed with pET28a+ (lane 3) or pET28a+/HA-magA-myc (lanes 4–7). Samples 
were separated on a denaturing gel under reducing conditions and stained with Coomassie Blue. 
Coomassie staining was not sensitive enough to detect protein from molecular weight standards 
for estimating protein masses. Untransformed cells (lanes 1–2) are compared to those 
transformed with either the empty vector (lane 3) or the hybrid construct (lanes 4–7). After 
induction of MagA-transformed cells with IPTG, Coomassie-stained protein increases relative to 
both uninduced and untransformed cells; however, treatment with an extracellular iron 
supplement did not drastically alter protein expression. The estimated MW of HA-MagA-Myc is 
~54 kDa. 
  
 
Untransformed    Vector                  MagA 
IPTG              -       +        -          -        -         +        +  
Fe                   -       -         -          -        +         -        +  
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Appendix 5. Longitudinal relaxation rates for MagA expressing E. coli BL21(DE3)  
Sample R1 (s-1) a SEM (s-1) n-value 
BL21(DE3) 1.70 a 0.06 5 
BL21(DE3)/pET28a+ 1.68 a 0.00 3 
BL21(DE3)/magA + Fe 1.92 b 0.04 3 
BL21(DE3)/magA + IPTG 1.33 c 0.02 3 
BL21(DE3)/magA + Fe + IPTG 1.33 c 0.04 3 
a Letters designate statistically significant differences in R1 values between transformed E. coli 
strains where values followed by the same letter are not significantly different based on a one-
way ANOVA and Tukey’s test. 
R1 of untransformed BL21(DE3) is significantly higher than that of vector-transformed, or 
induced magA-transformed BL21(DE3) +/- Fe (p < 0.001). Induced MagA-transformed bacteria 
have lower longitudinal relaxivity than empty vector or uninduced MagA-transformed E. coli (p 
< 0.05). 
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Appendix 6. Representative transverse relaxation decay curves for L. crispatus ATCC33820 
diluted in gelatin. Signal intensity was plotted against echo time (TE) to obtain R2 (A) and R2* 
(B) decay curves for L. crispatus serially diluted 1/2 in gelatin. 
A 
B 
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Appendix 7. Transverse and longitudinal relaxation rates for washed or unwashed E. coli 
BL21(DE3)  
R2 Relaxation Rate (s-1) Mean SD SEM 
BL21(DE3) / LB 45.82 37.82 43.93 44.43 44.81 43.36 3.17 1.42 
BL21(DE3) / PBS 46.25 37.01 46.08 44.23 - 43.39 4.35 2.18 
Gelatin / LB 0.55 1.09 2.74 2.71 - 1.77 1.12 0.56 
Gelatin / PBS 1.19 1.21 1.10 1.17 - 1.17 0.05 0.02 
 
R2* Relaxation Rate (s-1) Mean SD SEM 
BL21(DE3) / LB 41.32 35.92 39.63 41.66 45.77 40.86 3.57 1.59 
BL21(DE3) / PBS 41.29 35.21 42.81 39.91 - 39.80 3.28 1.64 
Gelatin / LB 2.71 2.43 4.39 2.87 - 3.10 0.88 0.44 
Gelatin / PBS 1.54 1.52 1.63 1.50 - 1.55 0.06 0.03 
 
R1 Relaxation Rate (s-1) Mean SD SEM 
BL21(DE3) / LB 1.55 1.58 1.85 1.78 1.75 1.70 0.13 0.06 
BL21(DE3) / PBS 1.66 1.52 2.11 1.94 - 1.77 0.27 0.13 
Gelatin / LB 0.62 0.62 0.65 0.64 - 0.63 0.02 0.01 
Gelatin / PBS 0.51 0.51 0.53 0.53 - 0.52 0.01 0.01 
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Appendix 8. Transverse and longitudinal relaxation rates of E. coli strains 
R2 Relaxation Rate (s-1) Mean SD SEM 
BL21(DE3)  45.82 37.82 43.93 44.43 44.81 43.36 3.17 1.42 
MG1655 51.34 51.88 47.41 - - 50.21 2.44 1.41 
Nissle 26.52 28.91 30.83 - - 28.75 2.16 1.25 
25922 15.50 25.96 26.05 - - 22.50 6.07 3.50 
67 30.20 39.58 36.23 - - 35.34 4.75 2.74 
AD110 30.77 25.18 19.11 - - 25.02 5.83 3.37 
GR-12 32.83 46.33 47.21 - - 42.12 8.06 4.65 
536 51.08 31.88 33.14 - - 38.70 10.74 6.20 
J96 45.39 51.35 52.84 - - 49.86 3.94 2.28 
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R2* Relaxation Rate (s-1) Mean SD SEM 
BL21(DE3)  41.32 35.92 39.63 41.66 45.77 40.86 3.57 1.59 
MG1655 45.01 47.58 45.53 - - 46.04 1.36 0.78 
Nissle 24.13 29.77 27.77 - - 27.22 2.86 1.65 
25922 13.91 24.18 24.56 - - 20.88 6.04 3.49 
67 28.42 36.15 32.45 - - 32.34 3.87 2.23 
AD110 28.70 22.36 17.78 - - 22.95 5.48 3.17 
GR-12 30.82 41.91 39.41 - - 37.38 5.82 3.36 
536 46.45 30.07 32.37 - - 36.30 8.87 5.12 
J96 38.66 48.61 48.93 - - 45.40 5.84 3.37 
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R1 Relaxation Rate (s-1) Mean SD SEM 
BL21(DE3)  1.55 1.58 1.85 1.78 1.75 1.70 0.13 0.06 
MG1655 1.52 1.74 1.72 - - 1.66 0.12 0.07 
Nissle 1.29 1.45 1.53 - - 1.42 0.12 0.07 
25922 1.07 1.31 1.29 - - 1.22 0.13 0.08 
67 1.45 1.76 1.69 - - 1.63 0.16 0.09 
AD110 1.33 1.38 1.22 - - 1.31 0.08 0.05 
GR-12 1.40 1.72 1.91 - - 1.68 0.26 0.15 
536 1.81 1.53 1.57 - - 1.64 0.15 0.09 
J96 1.70 1.99 1.95 - - 1.88 0.16 0.09 
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Appendix 9. ICP-MS iron and manganese content of E. coli strains 
Fe content (µg Fe / mg protein) Mean SD SEM 
BL21(DE3) 0.824 0.770 0.848 0.892 1.040 0.561 0.823 0.157 0.064 
MG1655 0.480 0.489 0.530 - - - 0.500 0.027 0.015 
Nissle 0.400 0.471 0.423 0.437 - - 0.433 0.030 0.015 
25922 0.914 0.700 0.807 - - - 0.807 0.107 0.062 
67 0.622 1.116 0.450 0.628 - - 0.704 0.287 0.143 
AD110 0.443 0.463 0.492 - - - 0.466 0.025 0.014 
GR-12 0.630 0.483 0.346 - - - 0.486 0.142 0.082 
536 1.050 0.581 0.507 - - - 0.713 0.294 0.170 
J96 1.070 0.729 0.671 - - - 0.823 0.216 0.124 
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Mn content (µg Mn / mg protein) Mean SD SEM 
BL21(DE3) 0.042 0.046 0.059 0.065 0.112 0.093 0.070 0.028 0.011 
MG1655 0.066 0.098 0.095 - - - 0.086 0.018 0.010 
Nissle 0.056 0.060 0.072 0.047 - - 0.059 0.010 0.005 
25922 0.073 0.040 0.070 - - - 0.061 0.018 0.011 
67 0.120 0.153 0.120 0.223 - - 0.154 0.049 0.024 
AD110 0.060 0.067 0.084 - - - 0.070 0.012 0.007 
GR-12 0.093 0.073 0.071 - - - 0.079 0.012 0.007 
536 0.126 0.115 0.174 - - - 0.138 0.031 0.018 
J96 0.109 0.107 0.141 - - - 0.119 0.019 0.011 
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Appendix 10. Transverse and longitudinal relaxation rates of MagA-expressing E. coli 
BL21(DE3) 
R2 Relaxation Rate (s-1) Mean SD SEM 
Untransformed  45.82 37.82 43.93 44.43 44.81 43.36 3.17 1.42 
Untransformed 
+ Fe 
60.00 60.29 50.47 - - 56.92 5.59 3.23 
Vector 33.81 39.75 41.73 - - 38.43 4.12 2.38 
MagA + Fe 41.07 39.91 45.40 - - 42.13 2.89 1.67 
MagA + IPTG 28.38 31.12 30.86 - - 30.12 1.51 0.87 
MagA + Fe + 
IPTG 
30.30 28.73 32.11 - - 30.38 1.69 0.98 
 
R2* Relaxation Rate (s-1) Mean SD SEM 
Untransformed  41.32 35.92 39.63 41.66 45.77 40.86 3.57 1.59 
Untransformed 
+ Fe 
54.40 52.70 43.79 - - 50.30 5.70 3.29 
Vector 33.96 39.38 39.13 - - 37.49 3.06 1.77 
MagA + Fe 38.26 37.61 40.65 - - 38.84 1.60 0.92 
MagA + IPTG 26.85 31.66 32.77 - - 30.43 3.15 1.82 
MagA + Fe + 
IPTG 
27.42 26.83 34.21 - - 29.49 4.10 2.37 
141 
 
 
R1 Relaxation Rate (s-1) Mean SD SEM 
Untransformed  1.55 1.58 1.85 1.78 1.75 1.70 0.13 0.06 
Untransformed 
+ Fe 
2.06 2.09 2.00 - - 2.05 0.05 0.03 
Vector 1.69 1.68 1.68 - - 1.68 0.01 0.00 
MagA + Fe 1.93 1.85 1.99 - - 1.92 0.07 0.04 
MagA + IPTG 1.3 1.37 1.33 - - 1.33 0.04 0.02 
MagA + Fe + 
IPTG 
1.3 1.41 1.28 - - 1.33 0.07 0.04 
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Appendix 11. ICP-MS iron and manganese content of MagA-expressing E. coli BL21(DE3) 
Fe content (µg Fe / mg protein) Mean ^ SD SEM 
Untransformed 0.824 0.770 0.848 0.892 1.040 0.561 0.823 0.157 0.064 
Untransformed 
+ Fe 
1.096 1.398 0.487 0.543 - - 0.881 0.441 0.220 
Vector 1.457 0.406 0.965 - - - 0.943 0.526 0.304 
MagA + Fe 1.140 1.163 1.019 - - - 1.107 0.077 0.045 
MagA + IPTG 0.652 0.734 0.653 - - - 0.680 0.047 0.027 
MagA + Fe + 
IPTG 
0.891 0.764 - - - - 0.828 - - 
^ Median is displayed for samples where n < 3. 
 
Mn content (µg Mn / mg protein) Mean SD SEM 
BL21(DE3) 0.042 0.046 0.059 0.065 0.112 0.093 0.070 0.028 0.011 
Untransformed 
+ Fe 
0.171 0.088 0.044 0.133 - - 0.109 0.055 0.028 
Vector 0.319 0.108 0.104 - - - 0.177 0.123 0.071 
MagA + Fe 0.160 0.186 0.148 - - - 0.165 0.019 0.011 
MagA + IPTG 0.019 0.032 0.027 - - - 0.026 0.007 0.004 
MagA + Fe + 
IPTG 
0.019 0.019 0.015 - - - 0.018 0.002 0.001 
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Appendix 12. Transverse and longitudinal relaxation rates of various bacterial species 
R2 Relaxation Rate (s-1) Mean SD SEM 
P. aeruginosa PA01 33.48 30.63 31.76 - 31.96 1.44 0.83 
S. epidermidis 
ATCC35984 
25.84 26.33 29.59 - 27.25 2.04 1.18 
K. pneumoniae 280 28.50 31.39 30.22 - 30.04 1.45 0.84 
E. faecalis 
ATCC33186 
37.98 32.85 22.82 - 31.22 7.71 4.45 
P. mirabilis 296 16.71 16.86 17.51 21.92 18.25 2.47 1.24 
S. aureus USA300 31.93 29.70 18.54 - 26.72 7.17 4.14 
S. aureus Newman 6.68 15.26 11.12 - 11.02 4.29 2.48 
L. gasseri 
ATCC33323 
86.92 89.50 58.05 63.65 74.53 16.00 8.00 
L. reuteri RC-14 28.99 29.33 28.28 - 28.87 0.54 0.31 
L. rhamnosus GR-1 44.08 48.39 52.69 - 48.39 4.31 2.49 
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R2* Relaxation Rate (s-1) Mean SD SEM 
P. aeruginosa 
PA01 
28.67 27.86 29.81 - 28.78 0.98 0.57 
S. epidermidis 
ATCC35984 
28.77 32.62 31.21 - 30.87 1.95 1.12 
K. pneumoniae 280 26.09 31.22 27.96 - 28.42 2.60 1.50 
E. faecalis 
ATCC33186 
38.17 32.50 22.95 - 31.21 7.69 4.44 
P. mirabilis 296 18.85 17.40 15.63 22.96 18.71 3.12 1.56 
S. aureus USA300 37.37 32.56 18.61 - 29.51 9.74 5.63 
S. aureus Newman 8.46 17.78 12.48 - 12.91 4.67 2.70 
L. gasseri 
ATCC33323 
75.48 84.21 55.97 57.97 68.41 13.70 6.85 
L. reuteri RC-14 26.75 26.89 24.65 - 26.10 1.25 0.72 
L. rhamnosus GR-1 41.17 44.75 46.96 - 44.29 2.92 1.69 
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R1 Relaxation Rate (s-1) Mean SD SEM 
P. aeruginosa PA01 0.63 1.22 1.17 1.15 1.04 0.27 0.14 
S. epidermidis 
ATCC35984 
1.38 1.46 1.43 1.69 1.49 0.14 0.07 
K. pneumoniae 280 1.26 1.25 1.25 - 1.25 0.01 0.00 
E. faecalis 
ATCC33186 
1.87 2.21 2.04 - 2.04 0.17 0.10 
P. mirabilis 296 0.83 0.92 1.02 - 0.92 0.09 0.05 
S. aureus USA300 1.49 1.46 1.17 - 1.37 0.18 0.10 
S. aureus Newman 1.47 0.76 1.34 1.12 1.17 0.31 0.15 
L. gasseri 
ATCC33323 
2.80 4.59 3.31 2.93 3.34 0.72 0.32 
L. reuteri RC-14 2.65 2.64 2.50 - 2.60 0.08 0.05 
L. rhamnosus GR-1 1.80 4.38 4.43 4.47 3.77 1.31 0.66 
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Appendix 13. ICP-MS iron and manganese content of various bacterial species 
Fe content (µg Fe / mg protein) Mean ^ SD SEM 
P. aeruginosa PA01 0.673 0.632 0.646 0.650 0.021 0.012 
S. epidermidis ATCC35984 0.675 1.728 0.821 1.075 0.570 0.329 
K. pneumoniae 280 1.271 0.691 2.005 1.322 0.659 0.380 
E. faecalis ATCC33186 0.192 0.239 0.332 0.254 0.071 0.041 
P. mirabilis 296 1.541 0.706 0.341 0.863 0.615 0.355 
S. aureus USA300 1.622 0.822 0.746 1.063 0.485 0.280 
S. aureus Newman 2.052 1.419 2.206 1.892 0.417 0.241 
^ Median is displayed for samples where n < 3. 
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Mn content (µg Mn / mg protein) Mean SD SEM 
P. aeruginosa PA01 0.027 0.024 0.035 0.029 0.006 0.003 
S. epidermidis ATCC35984 0.064 0.188 0.258 0.170 0.098 0.057 
K. pneumoniae 280 0.030 0.027 0.034 0.030 0.004 0.002 
E. faecalis ATCC33186 0.041 0.681 0.688 0.470 0.372 0.215 
P. mirabilis 296 0.018 0.014 0.003 0.012 0.008 0.004 
S. aureus USA300 0.196 0.075 0.149 0.140 0.061 0.035 
S. aureus Newman 0.217 0.286 0.371 0.291 0.077 0.045 
L. gasseri ATCC33323 0.140 1.345 1.720 1.068 0.826 0.477 
L. reuteri RC-14 20.21 16.93 18.91 18.68 1.652 0.954 
L. rhamnosus GR-1 71.16 43.26 45.37 53.26 15.54 8.969 
L. crispatus ATCC33820 44.99 33.45 111.9 63.45 42.36 24.46 
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Appendix 14. Transverse and longitudinal relaxation rates of L. crispatus ATCC33820 
diluted in gelatin 
Fraction of L. 
crispatus 
R2 Relaxation Rate (s-1) Mean ^ SD SEM 
1/2  183.4 174.0 169.5 134.2 143.3 160.9 21.06 9.42 
1/4 94.00 91.81 91.31 68.25 50.31 79.14 19.23 8.60 
1/8 49.90 48.13 50.06 53.66 43.13 48.98 3.84 1.72 
1/16 25.45 25.28 26.21 37.21 30.36 28.90 5.09 2.27 
1/32 19.95 20.06 - - - 20.01 - - 
^ Median is displayed for samples where n < 3. 
 
Fraction of L. 
crispatus 
R2* Relaxation Rate (s-1) Mean ^ SD SEM 
1/2  173.4 223.6 195.0 142.9 165.2 180.02 30.68 13.72 
1/4 102.4 95.78 90.30 106.4 61.59 91.29 17.71 7.92 
1/8 47.56 48.87 52.41 67.24 57.43 54.70 7.98 3.57 
1/16 42.74 34.52 42.71 43.81 40.62 40.88 3.74 1.67 
1/32 25.67 26.15 - - - 25.91 - - 
^ Median is displayed for samples where n < 3. 
 
 
149 
 
Fraction of L. 
crispatus 
R1 Relaxation Rate (s-1) Mean SD SEM 
1/2  3.14 3.62 4.33 3.86 - 3.74 0.50 0.25 
1/4 4.09 4.16 4.41 3.55 4.07 4.06 0.31 0.14 
1/8 3.63 3.29 3.11 3 3.05 3.22 0.26 0.11 
1/16 1.93 2.01 2.11 1.91 1.74 1.94 0.14 0.06 
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Appendix 15. Transverse relaxation rates of L. crispatus ATCC33820 diluted in 5637 
bladder cells 
Fraction of L. crispatus Fraction of 5637 cells R2 Relaxation Rate (s-1) Median 
1/2  1/2 70.05 76.39 73.22 
1/4 3/4 52.81 - 52.81 
1/8 7/8 39.33 43.17 41.25 
1/16 15/16 32.58 21.66 27.12 
- 1/1 (100% 5637 cells) 16.32 9.22 12.77 
 
Fraction of L. crispatus Fraction of 5637 cells R2* Relaxation Rate (s-1) Median 
1/2  1/2 156.5 182.6 169.6 
1/4 3/4 97.21 - 97.21 
1/8 7/8 73.59 82.26 77.92 
1/16 15/16 67.70 75.84 71.77 
- 1/1 (100% 5637 cells) 18.38 25.64 22.01 
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Fraction of L. crispatus Fraction of 5637 cells R2' Relaxation Rate (s-1) Median 
1/2  1/2 86.45 106.21 96.33 
1/4 3/4 44.4 - 44.4 
1/8 7/8 34.26 39.09 36.68 
1/16 15/16 35.12 54.18 44.65 
- 1/1 (100% 5637 cells) 2.06 16.42 9.24 
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Appendix 16. Transverse and longitudinal relaxation rates of S, aureus USA300 iron 
acquisition and storage mutants in iron-replete and iron-deplete growth conditions 
S. aureus 
USA300 mutants 
Iron 
conditions † 
R2 Relaxation Rate (s-1) Mean ^ SD SEM 
WT High 31.93 29.70 16.40 26.01 8.40 4.85 
WT Low 36.17 17.29 19.25 24.24 10.38 5.99 
Δsfa/Δsbn High 27.41 28.20 - 27.80 - - 
Δsfa/Δsbn Low 22.41 18.67 18.45 19.84 2.23 1.28 
Δsfa/Δsbn/ΔftnA High 25.63 25.93 - 25.78 - - 
Δsfa/Δsbn/ΔftnA Low 21.38 21.12 20.31 20.94 0.56 0.32 
^ Median is displayed for samples where n < 3. 
 
S. aureus 
USA300 mutants 
Iron 
conditions † 
R2* Relaxation Rate (s-1) Mean ^ SD SEM 
WT High 37.37 32.56 18.61 29.51 9.74 5.63 
WT Low 42.60 18.67 20.64 27.30 13.28 7.67 
Δsfa/Δsbn High 28.23 29.02 - 28.63 - - 
Δsfa/Δsbn Low 25.19 18.16 18.96 20.77 3.85 2.22 
Δsfa/Δsbn/ΔftnA High 25.43 26.73 - 26.08 - - 
Δsfa/Δsbn/ΔftnA Low 21.37 22.18 21.18 21.58 0.53 0.31 
^ Median is displayed for samples where n < 3. 
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S. aureus 
USA300 mutants 
Iron 
conditions † 
R1 Relaxation Rate (s-1) Mean ^ SD SEM 
WT High 1.49 1.46 1.17 1.37 0.18 0.10 
WT Low 1.34 1.13 1.18 1.22 0.11 0.06 
Δsfa/Δsbn High 1.46 1.44 - 1.45 - - 
Δsfa/Δsbn Low 1.31 1.15 1.14 1.20 0.10 0.06 
Δsfa/Δsbn/ΔftnA High 1.40 1.36 - 1.38 - - 
Δsfa/Δsbn/ΔftnA Low 1.31 1.34 1.32 1.32 0.02 0.01 
^ Median is displayed for samples where n < 3. 
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Appendix 17. ICP-MS iron and manganese content of S. aureus USA300 iron acquisition 
and storage mutants in iron-replete and iron-deplete growth conditions 
S. aureus 
USA300 mutants 
Iron 
conditions † 
Fe content (µg Fe / mg 
protein) 
Mean ^ SD SEM 
WT High 1.622 0.822 0.746 1.063 0.485 0.280 
WT Low 0.213 - - 0.213 - - 
Δsfa/Δsbn High 0.990 - - 0.990 - - 
Δsfa/Δsbn Low 0.217 0.220 - 0.218 - - 
Δsfa/Δsbn/ΔftnA High 0.789 - - 0.789 - - 
Δsfa/Δsbn/ΔftnA Low 0.083 0.302 - 0.192 - - 
^ Median is displayed for samples where n < 3. 
 
S. aureus 
USA300 mutants 
Iron 
conditions † 
Mn content (µg Mn / mg 
protein) 
Mean ^ SD SEM 
WT High 0.196 0.075 0.149 0.140 0.061 0.035 
WT Low 0.072 - - 0.072 - - 
Δsfa/Δsbn High 0.096 - - 0.096 - - 
Δsfa/Δsbn Low 0.048 0.077 - 0.062 - - 
Δsfa/Δsbn/ΔftnA High 0.093 - - 0.093 - - 
Δsfa/Δsbn/ΔftnA Low 0.010 0.120 - 0.065 - - 
^ Median is displayed for samples where n < 3.  
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• Western Graduate Research Scholarship 2017-2018 ($1000) 
• Western Graduate Research Scholarship 2018-2019 ($3000) 
• FW Luney Entrance Scholarship 2017 ($2000) 
• Lawson Internal Research Fund Studentship 2017 ($15,000) 
• Dr. FW Luney Graduate Travel Award in Microbiology & Immunology ($2000) 
• Molecular Imaging program travel award 2018 ($450) 
• Microbiome and Probiotic Research Student Award ($12,125) 
• International Scientific Association for Probiotics and Prebiotics Students and Fellows 
Association travel award ($450 USD) 
• Molecular Imaging program travel award 2019 ($300) 
• International Scientific Association for Probiotics and Prebiotics Students and Fellows 
Association Outstanding Poster Award ($100 USD) 
